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Abstract Technological advances have enabled the analysis of cellular protein and RNA levels 
with unprecedented depth and sensitivity, allowing for an unbiased re-evaluation of gene regulation 
during fundamental biological processes. Here, we have chronicled the dynamics of protein and 
mRNA expression levels across a minimally perturbed cell cycle in human myeloid leukemia cells 
using centrifugal elutriation combined with mass spectrometry-based proteomics and RNA-Seq, 
avoiding artificial synchronization procedures. We identify myeloid-specific gene expression and 
variations in protein abundance, isoform expression and phosphorylation at different cell cycle 
stages. We dissect the relationship between protein and mRNA levels for both bulk gene 
expression and for over ∼6000 genes individually across the cell cycle, revealing complex, gene-
specific patterns. This data set, one of the deepest surveys to date of gene expression in human 
cells, is presented in an online, searchable database, the Encyclopedia of Proteome Dynamics 
(http://www.peptracker.com/epd/).
DOI: 10.7554/eLife.01630.001
Introduction
Recent technological advances in both mass spectrometry and nucleic acid sequencing have created 
new high throughput methods for the quantitative measurement of protein (Lamond et al., 2012; 
Mann et al., 2013) and RNA levels (Nagalakshmi et al., 2008; Wilhelm et al., 2008). This in turn has 
allowed studies, in both model organisms and human cells, which seek to document global proteomes 
and transcriptomes. For example, several laboratories have performed in-depth proteomic profiling 
of different human cell lines and independently concluded that the minimum number of proteins 
expressed in each cell line is on the order of 10,000 (Beck et al., 2011; Nagaraj et al., 2011). In a more 
recent study, the proteomes of 11 cell lines were profiled to a similar depth (Geiger et al., 2012). 
These data enable comparison of protein expression levels between cells that differ in tissue type, 
developmental origin, and mode of in vitro culture. At the transcriptome level, microarray analysis and 
RNA-Seq have been used to document global mRNA expression across extensive panels of human cells 
and tissues (Ramaswamy et al., 2001; Su et al., 2002), and to examine features of RNA regulation, 
such as alternative splicing (Braunschweig et al., 2013).
Although global quantification of mRNA levels is often more convenient, several studies have 
reported that for human cells and model organisms RNA levels alone are not uniformly predictive 
of protein levels (Gygi et al., 1999; Vogel et al., 2010; Maier et al., 2011; Nagaraj et al., 2011; 
Schwanhausser et al., 2011). The relationship between protein and mRNA abundance remains a 
topic of debate and the studies above highlight the challenges of relying on analysis of mRNA alone 
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to measure gene expression at the protein level. High throughput methods have also been used to 
analyze changes in gene expression in response to specific events, including cell cycle progression. 
Our objective in this study was to capitalize on these technological advances to provide an in-depth 
characterization of gene expression in human cells, including cell cycle-associated changes in the proteome 
and transcriptome. We thus address the key question of how different layers of gene expression affect 
corresponding levels of protein and mRNA in a biologically important, dynamic system.
The mitotic cell cycle is a conserved and highly regulated process in all eukaryotes, which has been 
categorized into four consecutive phases, that is, Gap 1 (G1), Synthesis (S), Gap 2 (G2) and Mitosis (M). 
Regulation of the cell cycle is important for controlling cell growth and proliferation and for coordinating 
the timing of major cellular events, such as DNA replication and cell division (Hunter and Pines 1994). 
Regulatory pathways and checkpoints allow cells to respond quickly to DNA damage and other forms 
of stress that require cell cycle arrest to prevent uncontrolled cell division (Hartwell and Kastan, 1994; 
King et al., 1994; Elledge, 1996; Pines, 1999). Many signaling mechanisms also impact on the control 
of cell cycle to allow cells to grow and divide in response to both developmental and environmental 
cues. Misregulation of the cell cycle machinery can lead to inappropriate cell proliferation, as often 
seen in neoplastic disease.
There are significant technical challenges involved in the analysis of cell cycle-dependent regulation 
of gene expression. Most cell cycle analyzes make use of cell synchronization methods to enrich popula-
tions of cells at specific cell cycle stages in sufficient quantities for biochemical characterization. For 
example, multiple strategies have been used to characterize levels of mRNA expression at different 
cell cycle stages in the budding yeast, Saccharomyces cerevisiae, including conditional knockdown of 
cell cycle regulators, withdrawal of growth factors, use of chemical inhibitors and physical size separation 
eLife digest Cells are complex environments: at any one time, thousands of different genes act 
as molecular templates to produce messenger RNA (mRNA) molecules, which themselves are 
templates used to produce proteins. However, not all genes are active at all times inside all cells: as 
cells grow and divide as part of the cell division cycle, genes are switched on and off on a regular 
basis. Similarly, the patterns of mRNA and protein production are different in, say, immune and skin 
cells.
In recent years, the tools available for detecting mRNA molecules and proteins have become 
more powerful, allowing researchers to move beyond just measuring the total amounts of mRNA 
and protein in the cell to now measuring individual amounts of specific mRNA and protein 
molecules encoded by specific genes. However, it has been a challenge to make these 
measurements at different stages of the cell cycle. Most of the methods used to do this have 
involved artificially ‘arresting’ the cell cycle, which can lead to side effects that are difficult to 
account for.
Ly et al. have now overcome these problems using a combination of three methods to measure 
the levels of mRNA and protein molecules associated with over 6000 genes in human cancer cells 
derived from myeloid leukemia. Exploiting the fact that cells change size during the cell cycle, Ly et 
al. used a centrifugation technique to separate cells based on their size and, therefore, the stage of 
the cell cycle they were at, thus avoiding the need to arrest the cell cycle. An approach called 
RNA-Seq was then employed to measure the levels of the different mRNA molecules in the cells, 
and a device called a mass spectrometer was used to identify and measure the levels of many 
different proteins.
In addition to being able to follow the level of mRNA and protein production for a large number 
of genes throughout the cell division cycle, while also obtaining detailed information about how 
many of the proteins are modified, Ly et al. discovered that—contrary to expectations—low 
numbers of mRNA molecules were sometimes associated with high numbers of the corresponding 
protein, and vice versa. This work provides a better understanding of the complex relationship 
between the levels of an mRNA and its corresponding protein product, and also demonstrates how 
it may be possible to detect subtle but important differences between cell types and disease states, 
including different types of cancer.
DOI: 10.7554/eLife.01630.002
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by centrifugal elutriation (Cho et al., 1998; Spellman et al., 1998). Large-scale transcriptome analyzes 
have also been performed in mammalian cells, particularly in HeLa cells, to compare mRNA expression 
levels across the cell cycle (Cho et al., 2001; Whitfield et al., 2002). More recently, several groups 
have also examined cell cycle variation in the mammalian proteome and phosphoproteome in cell line 
models (Ohta et al., 2010; Olsen et al., 2010; Pagliuca et al., 2011; Lane et al., 2013). The established 
methods to achieve highly synchronized mammalian cells usually involve arresting cells, either by inducible 
genetic depletion of factors needed to drive cell progression, or by drug treatments that either activate 
checkpoints, block major metabolic pathways, or else disrupt the mitotic spindle. Inhibiting or depleting 
essential factors and activities needed for proper cell cycle progression, however, may in turn cause 
side effects that alter gene expression independent from direct, cell cycle-based regulation (Cooper 
et al., 2007).
An additional challenge is that several studies have suggested that there may be tissue-specific 
plasticity in cell cycle regulation (Pagano and Jackson, 2004). For example, studies in mice with genetic 
deletions of D-type cyclins have shown that the hematopoietic system is the only tissue that requires 
D-type cyclins for cell proliferation (Kozar et al., 2004). In contrast to epithelial tumor cell lines, large-
scale studies examining protein expression in hematopoietic cells are sparse, with the Jurkat-T and K562 
cell lines being the only immune cell lines comprehensively profiled (Geiger et al., 2012). To the best of 
our knowledge, there have been no previous large-scale studies on myeloid cell cycle gene expression.
We have addressed these challenges by undertaking a high-resolution proteomic analysis of cell cycle 
gene expression in human NB4 cells. These cells are derived from the myeloid lineage and have been 
widely used as a model system for studying acute promyelocytic leukemia and myeloid biology (Drexler 
et al., 1995), due to their ‘undifferentiated’ promyelocyte state (Grisolano et al., 1997; He et al., 1997; 
Zhu et al., 2005). The data characterize the proteome of NB4 cells to a depth of over 10,000 proteins, 
with high average sequence coverage, including analysis of isoform expression and post-translational 
phosphorylation. We analyze cell cycle-regulated gene expression in NB4 cells at both the protein and 
mRNA level, using counterflow centrifugal elutriation (Banfalvi, 2008) combined with high-throughput, 
label free mass spectrometry-based proteomics and RNA-Seq. We identify subsets of genes encoding 
proteins whose abundance is cell cycle regulated, including novel factors, isoforms, and phosphorylation 
sites. All of the resulting data have been incorporated into the Encyclopedia of Proteome Dynamics 
(http://peptracker.com/epd/), an online, free to access, searchable database.
Results
Experimental design
Our goal was to obtain deep proteome coverage that would document global gene expression in the 
human myeloid cell lineage and to combine this with an unbiased, quantitative chronology of changes in 
gene expression across the mitotic cell cycle, with minimal perturbation to cellular physiology. To achieve 
this, we analyzed the human NB4 promyelocytic leukemia cell line using a strategy that combines 
centrifugal elutriation (Banfalvi, 2008), a physical method of enriching cell populations at different cell 
cycle stages, with high throughput analyzes of both protein and poly(A)+ mRNA levels. This strategy 
is outlined schematically in Figure 1. First, six elutriated fractions were collected from an unsynchronized 
population of NB4 cells grown in normal, label free medium. Second, to obtain deep proteomic 
information with high peptide and protein coverage, extracted proteins from each elutriated fraction 
were digested with trypsin and/or LysC and further fractionated by offline peptide chromatography prior 
to mass spectrometric analysis. As described below, this allowed quantitative profiling of the NB4 
proteome to a depth of >10,000 proteins, with high mean sequence coverage (∼38%). Third, poly(A) + 
RNA was also isolated from each of the same elutriated NB4 cell fractions that were used to isolate 
proteins and analyzed by an RNA-Seq transcriptomics workflow (Figure 1). This allowed us to quantitate 
transcripts from 12,078 protein coding genes, including 9667 genes whose mRNA expression was 
measured separately in each of the three pooled, elutriated fractions and in asynchronous cells.
Enrichment of cell cycle phases by centrifugal elutriation
Cells from an asynchronous, unfractionated NB4 cell culture and from each of the six elutriated fractions 
were analyzed by both flow cytometry and protein blotting to characterize their cell cycle profiles 
(Figure 2). First, cells in the total unfractionated NB4 population and in each of the six elutriated fractions 
were stained with propidium iodide (PI) and analyzed by flow cytometry. Histograms showing the results 
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of PI fluorescence measurements confirm that 
there is a pronounced differential enrichment 
for populations of cells in G1–G2 and M phases 
across elutriated fractions 1–6 (Figure 2A). The 
proportion of cells in each cell cycle phase was 
calculated by fitting the data to the Watson 
model (Watson et al., 1987). Fractions F1 and 
F2 were enriched in G1 cells, F3 and four were 
enriched in S phase cells and F5 and F6 were 
enriched in G2 and M phase cells (G2&M).
Second, we used immunoblotting to compare 
the levels of selected marker proteins, whose 
expression across the cell cycle is known, with the 
enrichment for each cell cycle stage detected 
by flow cytometry (Figure 2B). Equal amounts of 
total NB4 proteins from either the asynchronous 
cell population or from each elutriated fraction 
were separated by SDS-PAGE, electroblotted 
onto nitrocellulose and marker proteins detected 
using specific antibodies, as described in the 
‘Materials and methods’. This shows that, as 
expected, GAPDH is expressed at similar levels 
across all fractions, while cyclin E, which is a marker 
for the G1/S transition, has maximal expression in 
fractions F1 and F2. In contrast, markers for G2 
and M phase cells, such as cyclin B1, aurora kinase 
B and phospho-Histone H3 (S10), all have maximal 
expression in the last fractions (F5 and F6). All 
of the protein blotting data are thus consistent 
with the profiles of cell cycle stage enrichment 
deduced from the flow cytometry analysis and 
confirm that the six elutriated fractions are differen-
tially enriched for NB4 cells at different stages of 
progression through interphase and into mitosis.
We separately tested for viability of the collected 
NB4 cells post elutriation. Re-inoculation of the 
fractionated NB4 cells into tissue culture medium 
showed that the bulk of the cells survived the 
elutriation procedure with high viability and 
minimal damage and rapidly resumed growth 
when returned to culture, as judged by subsequent 
FACS analysis of the replated cells (Figure 2C, 
right). Elutriated NB4 cells were of similar size 
and granularity (as measured by forward and side 
scatter, Figure 2C, left), as a control NB4 cells 
that were not exposed to elutriation.
In summary, based on the combination of flow 
cytometry, immunoblot, and cell culture analyzes, 
we conclude that the elutriation strategy provides 
an effective physical method for fractionating 
unsynchronized populations of human immune 
NB4 cells into viable subpopulations of cells that 
are enriched in distinct cell cycle phases, with 
minimal perturbation to normal cell physiology 
and viability. Further, the elutriation methodology 
is highly reproducible, as documented below.
Figure 1. Experimental workflow. NB4 cells were 
harvested and fractionated by cell size using centrifugal 
elutriation. Six fractions were collected and processed 
separately for transcriptomics and proteomics. For 
proteomics, cells were lysed and digested with either 
Lys-C or Lys-C/trypsin. Peptides were then separated  
by two orthogonal modes of chromatography prior to 
analysis using an Orbitrap mass spectrometer. Data 
normalization, peak picking, database searching, 
peptide and protein identification were performed using 
the MaxQuant software suite. For transcriptomics, cells 
from the six fractions were pooled into three (G1, S, and 
G2&M-enriched fractions). Total RNA was extracted, and 
subjected to poly(A)+ tail selection. Poly(A)+ transcripts 
were shattered, reverse transcribed to establish cDNA 
libraries, which were sequenced using Illumina paired-
end sequencing technology. Reads were aligned to the 
human genome (build hg19) using TopHat, and then 
used for quantitative gene expression analysis of known 
protein coding genes using Cufflinks.
DOI: 10.7554/eLife.01630.003
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Figure 2. Validation of cell cycle enrichment by centrifugal elutriation. (A) Cells from asynchronous cells (top left) and each elutriation fraction (top right) 
were stained with a DNA-binding fluorescent dye and analyzed with flow cytometry. Proportions of cells in each cell cycle phase (bottom) were estimated 
using the Watson model. Fractions 1 and 2 (F1 and F2) are enriched in G1, fractions 3 and 4 (F3 and F4) are enriched in S, and fractions 5 and 6 (F5 and F6) 
Figure 2. Continued on next page
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Estimation of biological and technical variance
To evaluate the biological and technical reproducibility of the elutriation strategy, we performed three 
rounds of elutriation on NB4 cultures harvested on different days. Proteins were isolated from each 
elutriated fraction from each biological replicate. Samples were processed for mass spectrometry 
using a Single Shot workflow and analyzed in technical triplicate by reversed phase LC-MS/MS. Label 
free intensities were calculated from MS peptide-extracted ion chromatograms, as previously described 
(Luber et al., 2010). Comparison of the label free intensities within both the technical and biological 
replicates shows that the average Pearson correlation coefficients are greater than 0.97, indicating 
that both the elutriation-based cell cycle enrichment and the label free MS-based peptide quantitation 
methods are highly reproducible (Figure 3—figure supplement 1).
Characterization of the global NB4 cell proteome
To achieve deep coverage of the total NB4 cell proteome, we used a proteomic workflow combining 
digestion with two proteases with extensive pre-fractionation of peptides prior to MS analysis. Thus, 
protein samples isolated from each elutriate from a single elutriation experiment were divided and 
digested with either Lys-C alone (Lys-C), or double digested with Lys-C and Trypsin (Trypsin-DD). 
The resulting peptides were separated by analytical, hydrophilic Strong Anion eXchange (hSAX) 
chromatography into 12 fractions (Ritorto et al., 2013). Each fraction was then analyzed by LC-MS/MS.
Using the proteomics workflow described above, over 150,000 peptides were identified (Dataset 
S1, entire file available at Dryad, Ly et al., 2014), corresponding to 10,929 unique protein groups, over 
10,000 of which were detected with two or more peptides. These proteins represent expression of 
more than 9000 genes. As shown in Figure 3A, the quantitative data set includes proteins whose 
MS-measured extracted ion chromatogram intensities span eight orders of magnitude, which corresponds 
to at least four orders of magnitude in protein copy number (Nagaraj et al., 2011). A wide variety of 
biological functions are captured, reflected by the wide range of GO annotations, from low abundance 
proteins involved in transcription, to very high abundance proteins, such as histones and factors involved 
in ribosome subunit assembly (Figure 3A).
Given the wide range of protein expression levels, the bulk of protein abundance in NB4 cells 
results from the expression of a relatively small number of proteins, as is shown in a cumulative protein 
abundance plot (Figure 3B). Thus, half of the total protein molecules expressed correspond to only 
∼90 highly abundant proteins (0.9% of the proteins detected), which is similar to previous reports 
on other cell types (Nagaraj et al., 2011). In the other extreme, 10% of the total protein abundance 
reflects the expression of over 9000 different proteins, which highlights the prerequisite of detecting 
proteins across a wide range of abundance values for comprehensive proteome characterization.
We have generated here deep coverage of the NB4 proteome with a group of over 10,000 proteins 
identified that are each supported by an average of 15 separate peptides (Supplementary file 1). 
In total, 154,985 sequence-unique peptides were detected, of which 30.8% were identified by only 
Lys-C, and 50.5% by only Trypsin-DD, as shown in Figure 3C. These peptides map to a total of 
1,976,427 unique amino acid locations in the UniProt Human Reference Proteome (Figure 3D), yielding 
on average 139 amino acids sequenced per protein. As shown, Lys-C and Trypsin-DD peptides map to 
largely complementary sequence regions (Figure 3D). Thus, the combined use of these two proteases 
significantly increases the overall sequence coverage. As shown in Figure 3E, use of complementary 
proteases improves the mean sequence coverage by over 8% compared with a single digestion 
method. This yields a combined mean sequence coverage of ∼38% for over 10,000 proteins, providing 
one of the most detailed protein expression maps so far reported. Furthermore, using the double 
protease strategy, many proteins with low sequence coverage based on single protease digestion 
are enriched in G2 and M phase (G2&M). (B) Immunoblot analyses of the protein lysates for known cell cycle phase-specific markers (cyclin E, 
phospho-Histone H3 S10, aurora kinase B, cyclin A, and cyclin B1) are consistent with previous literature and the enrichment profiles in (A). (C) Forward 
scatter and side scatter plots (first column) and cell cycle distributions (remaining columns) for three representative fractions post inoculation (F1, F4, and 
F6). The forward and side scatter plots for each elutriated fraction are shown in cyan, and are directly compared with the same plot for asynchronous 
cells, which is shown in red. Cell cycle distributions of the three fractions are measured directly after elutriation (0 hr), and 2 and 4 hr after inoculation into 
tissue culture medium. Note that the cell cycle distributions shown includes cells with <2N DNA content.
DOI: 10.7554/eLife.01630.004
Figure 2. Continued
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Figure 3. Quantitative, in-depth characterization of a myeloid leukemia proteome. (A) A histogram of log-transformed protein abundance (iBAQ-scaled 
protein intensities). Quartile regions are shown in different colors, and enriched gene ontology terms (p<0.01) are shown above each region.  
(B) A cumulative plot of protein abundance, as estimated using iBAQ-scaled intensities. In total, 10,193 proteins were identified with at least two 
supporting peptides per protein. Protein abundances follow an exponential increase, with 90 proteins (0.9%) constituting 50% of the bulk protein mass, 
and 1028 proteins (10%) constituting 90% of the bulk protein mass. The remaining protein identifications (9075 or 89.1%) comprise less than 10% of the 
bulk protein mass in NB4 cells. (C and D) Venn diagrams showing the total number of sequence-unique peptides (154,985) and amino acid coverage 
(1,976,427) split by digestion method. Lys-C increases the number of peptides identified by 44% relative to Trypsin-DD. Amino acid coverage was 
calculated by mapping sequences back to an assembled proteome. Over 30% of the amino acids detected using Lys-C digestion reside in sections of 
protein sequences that are complementary to Trypsin. In summary, complementary digestion methods substantially increase the overall sequence 
coverage, as shown in (E). Combining data from both methods boosts the mean sequence coverage to 37.8% with comprehensive proteome depth of 
over 10,000 proteins.
DOI: 10.7554/eLife.01630.005
The following figure supplements are available for figure 3:
Figure supplement 1. Estimation of technical and biological variances among replicates indicates highly reproducible protein quantitation. 
DOI: 10.7554/eLife.01630.006
Figure supplement 2. Comparison of expected versus observed amino acid and gene ontology frequencies reveals no major detection bias in the 
proteomics data set. 
DOI: 10.7554/eLife.01630.007
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(observed as a second, broad peak to the left in Figure 3E), are shifted to higher sequence coverage. 
High sequence coverage not only improves the accuracy of protein and isoform identification, it is also 
important for high resolution analysis of protein regulation during the cell cycle, as highlighted below.
We next evaluated the NB4 data set for possible detection bias, for example due either to differential 
efficiency of extracting distinct classes of protein in the lysates prepared, or to failure by MS to detect 
protein types featuring high levels of modification and/or unusual sequence combinations that are not 
cleaved efficiently into peptides. To address this, we compared the observed frequencies of GO terms 
and the amino acid proportions for all of the proteins detected in this NB4 cell data set with the 
corresponding predicted frequencies calculated from in silico translation of the entire human proteome 
(Figure 3—figure supplement 2). The Pearson correlation coefficients observed between these 
predicted and measured frequencies (r >0.98) indicate that the sampling of proteins in the NB4 data 
set is highly representative of the human proteome. While inevitably some expressed proteins have 
not been detected, particularly in the very low abundance range, we can effectively exclude that there 
is a major bias, either from under-sampling specific protein classes (e.g., membrane proteins), or from 
an absence of lower abundance proteins in general.
Comparison of the NB4 proteome with other human cell line proteomes
Next, we compared this proteome analysis of NB4 cells, a human promyelocytic leukemia cell line that 
grows in suspension culture, with other recent examples of in depth proteomic analysis of different 
human cell lines, most of which are adherent tumor cell lines, of either fibroblast or epithelial origin. 
This meta-analysis included protein data from 14 cell line proteomes: 3 × HeLa, 2 × U2OS, A549, 
GAMG, HEK293, K562, LnCap, MCF7, RKO, HepG2, and Jurkat-T (Lundberg et al., 2010; Beck et al., 
2011; Nagaraj et al., 2011; Geiger et al., 2012), which were consolidated and mapped to Ensembl 
Genes prior to comparison. The combined data set provides evidence of protein-level expression of 
over 11,000 human genes. Of these, a common set of ∼3000 genes are identified by protein data from 
all these cell lines, defining a core, shared proteome (Supplementary file 2). Interestingly, the abundance 
values of proteins in this core proteome span the full abundance range of the entire NB4 proteome. 
This suggests that the core proteome is not simply reflecting a detection bias towards abundant 
proteins. The core proteome is enriched in proteins associated with RNA processing, translation, cell 
cycle, and DNA metabolic processes, which together highlight key biological processes required for 
cell proliferation. In contrast, analysis of cell type-specific proteomes highlight specialized biological 
functions that are associated with cell lineage and mode of culture, as will be discussed below.
Approximately, 10% of the expressed genes we detected in NB4 cells at the protein level are exclusive 
to this study and have not been reported in large-scale proteomic studies of other human cell lines 
(listed in Supplementary file 2). Interestingly, this NB4-specific pool is enriched in proteins that regulate 
cation flux in the cell, proteins involved in the innate immune response, zinc finger proteins and 
transcription factors (>200), including proteins known to be important to leukemic and immune cell 
biology, such as RARα, RXRβ, CEBPα, GFI-1 and PU.1 (Zhu et al., 2001; Orkin and Zon, 2008).
We next focused on comparing the NB4 proteome with the most recent study describing in detail 
protein expression in several human cell lines (Geiger et al., 2012), including the K562 and Jurkat-T 
cancer cell lines derived from the immune lineage (myeloid and lymphoid, respectively), that are the 
most related to NB4 (myeloid). The other two cell lines compared (HeLa and MCF7) are derived from 
epithelial tumors. Pairwise comparisons were performed to determine sets of genes that are uniquely 
detected in each cell line. Enriched gene ontology terms for each set are shown in Figure 4A. Comparison 
of these cell line-specific subproteomes reveals proteins with functions that highlight not only the 
differences in lineage, but also distinguish mode of culture, for example suspension vs adherent 
culture. For example, HeLa- and MCF7-specific sets are enriched in genes involved in cell adhesion, 
such as cadherins and integrins, whereas the Jurkat-T-specific set is enriched in genes involved in T-cell 
selection and activation, such as CD1, CD3, and CD4 (Figure 4A).
For three out of the four cell lines, pairwise comparisons reveal specific transcription factors that are 
enriched in the NB4-specific data set, as similarly found for the broader comparison described above. 
In contrast, comparison of the NB4 proteome with the proteome of the myeloid K562 cells reveals that 
many transcriptional regulators are shared between these two myeloid cell lines. Thus, among the 
87 genes that express proteins in K562 and NB4, but which are not detected in MCF7 and HeLa (Geiger 
et al., 2012), 22 are either known or putative transcription factors including SP1 and JUN (Friedman, 
2002), and five have been annotated with gene ontology terms associated with myeloid differentiation 
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(Figure 4B). Further network analysis using the MSigDB transcription factor binding database 
(Subramanian et al., 2005; Matys et al., 2006), revealed evidence for cross-talk between JUN, SP1, and 
many of the additional genes whose expression was shared between K562 and NB4 cells, but not observed 
Figure 4. Identification of myeloid-specific factors in the NB4 proteome. (A) Pairwise comparisons between the NB4 proteome (this study, acute myeloid 
leukemia) and K562 (chronic myeloid leukemia), Jurkat-T (T-cell leukemia), HeLa (cervical carcinoma), and MCF7 (breast carcinoma) proteomes published 
by Geiger et al. (2012). Enriched gene ontology terms and the enrichment p-values are shown for each pairwise comparison. The observed cell-line 
specific gene ontology enrichments are consistent with the developmental origins of the cell lines (immune vs epithelial), and culturing conditions 
(suspension vs adherent). The NB4 proteome is highly enriched in transcription factors when compared to cell lines that are not in the myeloid lineage 
(Jurkat-T, HeLa, and MCF7), implying that there is set of shared transcription factors between NB4 and K562 that may be myeloid-specific. (B) A transcriptional 
regulatory network analysis of proteins identified in myeloid cells (NB4 and K562). Arrows connect transcription factors with their predicted gene 
substrates (MSigDB). JUN and SP1 appear to be regulatory hubs that can regulate the expression of numerous NB4- and K562-specific genes (Friedman, 
2002). Together, these data highlight a protein group that may have important transcriptional regulatory activity in myeloid cells. Circles indicate genes 
that are annotated as being involved in myeloid differentiation (red) or transcription (yellow).
DOI: 10.7554/eLife.01630.008
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in either MCF7 or HeLa (Figure 4B). Interestingly, immunohistochemical detection of SP1 protein levels by 
the Human Protein Atlas project (www.proteinatlas.org) showed ubiquitous expression and especially 
high levels in hematopoetic and placental tissues (Uhlen et al., 2010).
In summary, we have identified a specific set of proteins that are preferentially detected in myeloid 
cells and that may be important in specifying myeloid cell function. We conclude that deep proteome 
analysis helps to provide a molecular characterization of cell identity by defining sets of genes uniquely 
expressed in specific cell types.
Identification of proteins whose abundance varies across the cell cycle
Next, we studied how gene expression in NB4 cells varies across the cell cycle. To do this, we compared 
the subproteomes of the six, separate elutriated NB4 cell fractions and analyzed how protein abundance 
varies between the different cell cycle phases. To increase the accuracy of this analysis, we focused on 
a subset of the total NB4 proteomic data set for which we have protein abundance measurements in 
all six elutriated fractions and in the asynchronous samples. The 6505 proteins that meet this requirement 
are supported on average by over 22 distinct peptides per protein, and have a mean sequence coverage 
of >45%. An arbitrary fold-change cutoff of 2.0 (1.0 in the log2-transformed axis), was chosen here as 
the threshold value for cell cycle-regulated abundance change because we observed that this was 
sufficient to highly enrich for proteins annotated with cell cycle associated GO terms (p<<0.01), as 
shown in Figure 5A. Using these parameters, we identified a group of 358 proteins whose abundance 
varies across the cell cycle by twofold or more, corresponding to ∼5.5% of the high quality, filtered 
proteomic data set of 6505 proteins (Supplementary file 3).
This group of 358 proteins whose abundance is cell cycle regulated was clustered by intensity profiles, 
which resulted in seven distinct clusters. Scaled protein expression profiles by cluster are shown both 
as line graphs (Figure 5B) and as a heatmap (Figure 5D). Six clusters vary primarily by variations in 
their maximum expression in different elutriated fractions (clusters 1 through 6). In cluster 7, proteins 
show a marked decrease in abundance during S-phase and peak in the G2&M and G1 fractions (termed 
‘G2&M + G1’ cluster).
Approximately, half of the proteins whose abundance varies significantly across the cell cycle 
exhibit peak expression in elutriated fractions 5&6, corresponding to late S, G2, and M phases (Figure 5C). 
Proteins whose abundance peaks in S phase are the second most frequent class (27%), followed by 
proteins peaking in G1 (17%) and proteins that peak in both G2&M and G1 (7%). A large number of 
human proteins previously reported to be regulated during the cell cycle were identified in this unbiased 
data set. For example, proteins involved in origin licensing in G1, such as ORC1 (Origin Recognition 
Complex 1) and DNA replication factor CDT1, peak in G1. UNG (Uracil-DNA glycosylase), which is 
involved in DNA repair, and Cyclin A2 peak in S phase. Aurora kinase B and cyclins B1 and B2, which 
are proteins involved in mitosis, peak in G2&M (Murray, 2004; Musacchio and Salmon, 2007; 
Dephoure et al., 2008; Olsen et al., 2010).
The clusters above differ primarily in peak expression across the six elutriated fractions, which can 
also be broadly classed as G1-, S-, or G2&M-enriched. The six clusters were grouped into these three 
broader classifications (excluding cluster 7, which peaks in both fractions 1 and 6) and analyzed for 
enrichment of gene ontology terms (Table 1). Additionally, we tested whether the cyclical regulation 
of protein abundance may be explained, at least in part, by changes in transcription factor activity 
across the cell cycle. The UCSC TF database contains the predicted promoter binding sites for many 
important and well-studied transcription factors and is incorporated into the DAVID gene ontology 
enrichment tool. Thus, we also examined whether the promoters of genes encoding these proteins are 
differentially enriched in transcription factor binding sites.
Table 1 lists the corresponding enriched gene ontology terms and transcription factor binding sites 
by category. Each category is enriched in distinct annotations, indicating that different types and 
different functional classes of proteins are being regulated during separate phases of the cell cycle. In 
general, the GO terms we observe enriched in each phase are consistent with many of the activities and 
processes known and expected for that stage of cell cycle progression. For example, in the category 
with proteins whose abundance peaks in S phase, there is a clear enrichment for GO terms associated 
with DNA metabolic functions, reflecting DNA replication as the major metabolic event in S phase. 
Additionally, the promoters of genes encoding proteins that peak in S-phase are enriched with respect 
to predicted binding sites for E2F (Table 1), a transcription factor that is known to play major roles in 
regulating entry into the cell cycle and the G1–S transition (Mudryj et al., 1991). Interestingly, we 
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Figure 5. Identification of cell cycle-regulated proteins. (A) The fold change in label free intensities between any two fractions are shown as a histogram. 
To identify cell cycle-regulated proteins, an arbitrary fold change cutoff of 2.0 (1.0 in the log2-transformed axis) was set, as indicated by the border 
between the orange and blue boxes. Highly significant enriched gene ontology terms (p<<0.01) are shown above each group. A twofold change is 
sufficient to enrich for cell cycle related gene ontology terms, such as M-phase, nuclear division, and mitosis. (B) Clustering of the 358 cell cycle-regulated 
proteins identified in (A). Scaled protein intensity profiles were clustered by the phase of maximum expression, with the exception of a small minority of 
proteins that peaked in multiple phases. Graph titles indicate the phase that is enriched in that fraction. (C) The number of cell cycle-regulated proteins 
split by cluster. Half of the cell cycle-regulated proteins are maximally expressed in the G2&M phase of the cell cycle. (D) Scaled intensities are depicted 
as a heat map. Each vertical line represents a cell cycle-regulated protein, and the shading indicates the intensity (bright yellow being the most intense). 
Cell cycle regulators established in the literature are highlighted along the bottom of the heat map, and include cyclins A2, B1, B2, and CDT1.
DOI: 10.7554/eLife.01630.009
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identify members of the E2F family (E2F6 and E2F8) as proteins whose abundance peaks in S and G2&M 
phases, which is consistent with recent reports documenting their role in transcriptional inactivation of 
G1/S genes (Bertoli et al., 2013).
In contrast, the category containing proteins whose abundance peaks at G2&M phase is instead 
highly enriched for GO terms associated with cell division, M-phase, and NF-Y transcription factor 
binding sites in their promoters. The category containing proteins that peak in G1 and G2&M (cluster 7), 
meanwhile, is enriched for genes with promoters that have STAT3 transcription factor binding sites; 
indeed, 20 out of the 26 genes encoding these proteins (77%), have predicted STAT3 binding sites.
Notably, the GO term ‘cell cycle’ is only enriched in the S and G2&M clusters. Based on our current 
data (Figure 5C), this may reflect the fact that more cell cycle regulated proteins have peak abundance 
in S, G2, and M phase than in G1 phase. However, it may also illustrate a feature of the gene ontology 
annotation system used, linked with the preponderance of previous ‘cell cycle’ research that has 
concentrated specifically on analyzing either the entry of cells into mitosis or on studying events during 
chromosome segregation and mitotic progression and exit. However, our data demonstrate multiple 
proteins whose abundance is also ‘cell cycle regulated’ at other stages during interphase, outside of 
mitosis, which suggests that they should also be annotated with the GO term ‘cell cycle’.
Analysis of protein isoforms whose abundance varies across  
the cell cycle
In most cases, the protein groups identified by MS analysis correspond to groups of protein isoforms 
that usually originate from the same open reading frame. However, protein isoforms, even when 
encoded by the same gene, can have distinct biological properties and can differ in their subcellular 
localization patterns, interaction partners, and biological functions (Trinkle-Mulcahy et al., 2006; 
Ahmad et al., 2012; Kirkwood et al., 2013). The high sequence coverage achieved in this NB4 data 
set improved our ability to discriminate between separate protein isoforms. The peptide data map to 
33,575 separates protein isoforms in the Uniprot Human Reference Proteome. Quantitative peptide data, 
such as either intensities or spectral counts, are normally aggregated into protein groups by sequence 
similarity and shared peptide evidence. In this study, we have pooled quantitative data by protein 
isoform, which facilitates the analysis of isoform-specific cell cycle behavior (Figure 6). Given that current 
proteomics workflows achieve ∼30 to 40% mean sequence coverage at best, a comprehensive analysis 
Table 1. Enriched functional annotations among the cell cycle varying proteins
Peak phase Functional annotation Proteins % of total p value
G1 (42 proteins) transcription cofactor activity 5 12% 0.003
transcription factor binding 5 12% 0.012
S (110 proteins) phosphoprotein 82 75% 1.2E-07
E2F* 82 75% 0.002
DNA metabolic process 10 9% 0.012
positive regulation of  
gene expression
8 7% 0.037
cell cycle 11 10% 0.009
G2/M (180 proteins) M phase 26 14% 7.5E-20
cell cycle 41 23% 3.9E-19
phosphoprotein 94 52% 1.8E-06
NFY* 93 52% 3.6E-05
Complex (26 proteins) STAT3* 20 77% 0.003
nucleotide-binding 7 27% 0.015
Proteins were partitioned into four categories by peak phase and analyzed for functional annotation enrichment. 
Functional annotations include gene ontology terms and predicted transcription factor binding sites in the 
promoter region of the encoding gene. Enriched annotations, their enrichment p values, the number and 
percentage of proteins with the specified annotation are shown.
*Transcription factor binding sites from the UCSC TFBS database.
DOI: 10.7554/eLife.01630.010
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of isoform-specific variation remains challenging. However, the three examples selected below illustrate 
the importance of examining isoform-specific protein variation across the cell cycle.
Peptide-level MS data were re-analyzed in the context of predicted and known splice isoforms in 
the UniProt database (Kirkwood et al., 2013). To enhance data quality, we only considered ORFs that 
have at least two peptides with unique amino acid sequences per protein isoform that were quantified 
in all six elutriated fractions. These were screened for isoform-specific abundance variation across the 
cell cycle. Examples of cell cycle-regulated isoforms include proteins encoded by the genes CASC4, 
PPFIBP1, and SDCCAG8. Line graphs show the spectral counts across the six elutriated fractions 
(Figure 6). Peptide evidences and isoform-specific sequence motifs that target proteins for cleavage 
and/or degradation, which can affect the activity and abundance of one isoform differentially from the 
remaining isoforms, are depicted schematically in Figure 6.
We observed differential behavior for CASC4 isoforms, with the abundance of CASC4-1 and CASC4-2 
peptides substantially decreasing from G1 to G2&M, whereas CASC4-3 remains invariant (Figure 6A). 
An important point is that simply aggregating the peptide intensities for all of these CASC4 isoforms 
produces a relatively constant expression pattern across the elutriated fractions. Therefore, conven-
tional bottom-up MS analysis ignoring isoform variation would indicate that the CASC4 ORF gener-
ates a polypeptide that is not cell cycle regulated. In contrast, examining the data set with isoform 
resolution showed isoform-specific cell cycle regulation of separate polypeptides encoded by the 
CASC4 gene.
Figure 6. CASC4, PPFIBP1, and SDCCAG8 are examples of ORFs that encode multiple splice isoforms that behave differently across the cell cycle. 
Protein spectral count profiles across the six elutriated fractions for three open reading frames (ORFs) showing protein-level isoform-specific cell cycle 
variation: CASC4 (A), PPFIBP1 (B), and SDCCAG8 (C). Isoform sequences are shown schematically above each graph. Sequence regions for which direct 
peptide evidence was detected are shaded in blue, and sequence motifs known to be important in post-translational regulation are indicated.
DOI: 10.7554/eLife.01630.011
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PPFIBP1 was initially identified as a cell cycle-regulated protein using the isoform-naive methods 
described above. However, closer analysis shows that the PPFIBP1 gene encodes multiple isoforms 
that behave differentially across the cell cycle fractions. Thus, isoforms 1 through 4 vary in abundance 
across the cell cycle, whereas the abundance of isoform 5 remains relatively constant (Figure 6B). 
Interestingly, several D-box motifs associated with targeted protein degradation are only found in 
isoforms 1–4, suggesting a mechanism for the isoform-specific cell cycle regulation observed.
The SDCCAG8 gene encodes multiple protein isoforms: three that decrease from G1 to G2&M 
(isoforms 1, 3, and 4) and isoform 2 that instead peaks in S-phase (Figure 6C). As shown with CASC4 
above, aggregated peptide data for all isoforms of SDCCAG8 would indicate constant expression 
across the elutriated fractions, if interpreted as having all of the peptides belonging to a single protein 
species. However, as a result of the high sequence coverage obtained, it is apparent that the peptides 
from the SDCCAG8 gene belong to separate isoforms that are differentially regulated across the cell 
cycle. These three examples underline the value of high peptide sequence coverage that allows 
isoform-level resolution. The data also indicate that current analyzes likely underestimate the total 
number of cell cycle-regulated polypeptides, because with current methods many peptides are not 
detected and thus many isoforms still cannot be reliably discriminated.
Variation in protein phosphorylation across the cell cycle
Cell cycle progression is controlled not only by changes in protein abundance, but also by other protein 
properties, including post-translational modifications (PTMs). One of the most important and well-
characterized classes of PTM is reversible phosphorylation, which modulates the activity of numerous 
cell cycle regulatory proteins (Dephoure et al., 2008; Olsen et al., 2010). In this data set a total of 
2761 phosphopeptides were identified, of which 28% were detected with multiple phosphorylated 
residues in the same peptide (Supplementary file 4). Most of the phosphorylation sites identified 
were on Ser (64%), with the remaining sites evenly split between Thr (17%) and Tyr (16%) (Figure 7A). 
Many of the pTyr sites were found in abundant cytoskeletal proteins, such as actin, myosin, and titin 
(Supplementary file 4). Among the phosphorylation sites that were independently identified by 
MS/MS in all six elutriated fractions, 89 phosphorylated peptides varied in abundance by more than 
twofold (∼3% of phosphorylation sites detected, Supplementary file 5). These sites, which mapped to 
79 different proteins, were considered to be cell cycle regulated. Interestingly, only four of these 
cell cycle-regulated phosphosites mapped to proteins whose abundance varied by more than 
twofold across the cell cycle (Figure 7B). As shown in Figure 7C, most of the cell cycle-regulated 
phosphosites were on Ser (87%). The only cell cycle-regulated phosphotyrosine identified was 
mapped to Tyr15 of CDK2 and/or CDK1 (both these proteins upon digestion with Lys-C or trypsin, 
produce the same Tyr15-containing peptide). It has been previously shown that the activities of CDK2 
and CDK1 are modulated by differential phosphorylation of Tyr15 at different stages of the cell cycle 
(Gu et al., 1992).
We further identified cell cycle-regulated phosphorylated peptides that peak in abundance at 
different stages of the cell cycle (Figure 7D,E). Four examples of proteins whose phosphorylation status 
varies across the cell cycle are shown in Figure 7D. Several cell cycle-regulated phosphorylation sites 
were identified in histones (Figure 7D, right), which are known to be increasingly phosphorylated from 
G1 to G2&M (Sarg et al., 2006). In the case of TOP2A, which is a protein involved in modulating the 
topological state of DNA, levels of the peptide phosphorylated at Ser1377 peak in G1/S, whereas an 
increase in total TOP2A protein abundance is observed from G1 to G2&M. These data suggest two 
modes of TOP2A activity across the cell cycle: one that is modulated by phosphorylation at Ser1377 
during G1/S and a second that may require more copies of TOP2A in the later stages of the cell cycle. 
In the case of UNG, levels of both the phosphopeptide and the total protein abundance vary in a sim-
ilar manner across the cell cycle, suggesting that the phosphorylation stoichiometry at this site (Ser23) 
is relatively constant. In contrast, while the total abundance of TP53 protein is relatively constant, the 
phosphorylation level of Ser315 on TP53 varies significantly across the cell cycle.
Transcriptional regulation in NB4 cells across the cell cycle
To investigate the role of transcriptional regulation in the abundance changes observed at the protein 
level, we undertook a parallel large-scale RNA-Seq analysis of the NB4 cell transcriptome. This was 
performed both using asynchronous NB4 cells and cells enriched at different cell cycle stages by elutria-
tion. The RNA-Seq analysis was performed both in biological and technical duplicate.
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The combined transcriptomics data set detected mRNA expression from 12,078 genes in NB4 cells 
(Supplementary file 6). This data set was filtered to identify a subset of 9667 genes whose mRNA 
expression was quantified in each of the three elutriated samples (i.e., combined elutriated fractions 
F1+F2, F3+F4 and F5+F6). Pairwise comparisons between both the technical and biological replicates 
show high correlation (r >0.90), (Figure 8—figure supplement 1), albeit with higher variance than for 
replicate proteomics data sets (Figure 3—figure supplement 1). Nonetheless, given the overall high 
degree of reproducibility observed in the biological and technical replicate proteomics and transcriptomics 
data, we conclude that variance observed comparing protein and mRNA levels (as will be discussed 
below), predominantly represents biologically significant differences in protein and mRNA expression 
and cannot be simply explained by variability in either sample preparation and/or measurement error.
Next, we compared directly the expression levels of cognate protein and mRNAs from the same 
genes. To do this, our detailed proteome (8510 proteins) and transcriptome (mRNA from 9667 genes) 
Figure 7. Identification of cell cycle-regulated phosphopeptides. (A) A total of 2761 phosphorylation sites were identified without phosphopeptide 
enrichment, which are shown split by residue (Ser, Thr, and Tyr). Cell cycle regulated phosphosites are shown in green. The numbers on top of each bar 
indicate the total number of pSer, pThr, and pTyr residues detected, respectively. The proportions of cell cycle-regulated pSer, pThr, and pTyr, relative to the 
total pSer, pThr, and pTyr sites detected respectively, are shown as percentages. (B) Overlap between proteins whose abundances are cell cycle regulated 
and proteins whose phosphorylation is cell cycle regulated. (C) A breakdown of cell cycle-regulated phosphosites by residue. The number and the 
percentage of phosphosites relative to the total number of cell cycle regulated phosphosites are shown. (D) Scaled phosphopeptide intensity profiles 
plotted as a heatmap. Representative cell cycle-regulated phosphorylations that are established in the literature are shown along the top of the heatmap. 
(E) Scaled phosphopeptide and summed protein intensity profiles for four cell cycle regulated phosphorylated proteins (TOP2A, UNG, TP53, and histones). 
The peptide intensity graphs are annotated with the mapped phosphorylation site. For histones, several phosphopeptide profiles (light purple, light blue, 
and light orange) and the average (black) are shown on the same graph. The total histone intensity is calculated as the sum of all histones identified.
DOI: 10.7554/eLife.01630.012
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data sets from the asynchronous NB4 cell cultures were merged by mapping the respective protein 
and gene identifiers to Ensembl Gene IDs. Quantitative protein abundances (iBAQ-scaled, see 
‘Materials and methods’) from expression variants and isoforms that originate from the same gene 
were aggregated by summation. Histone transcripts were removed from the analysis, due to the 
known under-representation of poly(A)- mRNAs in our data sets.
In total, we could directly compare the abundances of cognate protein and mRNA for 6170 genes 
(Figure 8A). Qualitatively, this shows that overall, as expected, the levels of protein and mRNA from 
the same gene are clearly positively correlated. However, the moderate value of the Spearman rank 
correlation coefficient (0.63), indicates that this positive correlation is not strong enough to consider 
the level of mRNA alone as a reliable predictor of protein levels for many specific genes. The Spearman 
rank correlation coefficient of 0.63 measured here is within the upper quartile of the range of previously 
reported values for correlations between protein and mRNA levels in other mammalian cell types (Tian 
et al., 2004; Maier et al., 2009; Lundberg et al., 2010; Nagaraj et al., 2011; Schwanhausser et al., 
2011; Vogel and Marcotte, 2012).
We also compared the correlation between the expression levels of protein and mRNA from the 
same genes for the separate data sets derived from NB4 cell populations enriched by elutriation for 
G1, S, or G2&M phases (Figure 8B). This shows that there is little or no difference in the degree of 
correlation between protein and mRNA, with the same Spearman rank correlation coefficient (r = 0.65) 
at each of the G1, S, and G2&M phases. These correlation values are similar to what we measured in 
the asynchronous NB4 cell data set. We conclude that there is little or no global change in the overall 
relationship between bulk mRNA and protein levels in NB4 cells at different stages of interphase. 
Furthermore, based on our measurements and correlations of protein and mRNA levels across the 
elutriated fractions, the data are consistent with there being a large contribution from post-transcriptional 
mechanisms to controlling gene expression in NB4 cells.
Correlation of protein and mRNA expression patterns is cell cycle 
dependent for cell cycle-regulated proteins
Having established that absolute abundances of protein and mRNA are moderately correlated, and 
that this correlation is independent of cell cycle phase, we next compared specifically the protein and 
mRNA expression of the 358 proteins whose abundances are cell cycle regulated, as identified in our 
proteomic data set. First, we examined whether the correlation of absolute protein and mRNA abun-
dances in asynchronous cells is different for genes encoding proteins whose abundance is cell cycle 
regulated. As Figure 8C shows, the protein and mRNA correlation for these genes (r = 0.47) is weaker than 
the overall correlation for all expressed genes (0.63–0.65). These data suggest that post-transcriptional 
mechanisms may contribute to a larger extent in cell cycle-regulated gene expression, as compared 
with bulk gene expression.
We next separately compared the protein and mRNA levels in asynchronous NB4 cells for the four 
previously determined protein clusters (see Figure 5), which differ primarily by the phase in which 
peak expression occurs (i.e., G1, S, G2&M or G2&M+G1). As Figure 8D shows, correlation of protein 
and mRNA abundances is moderate (r = 0.57) for cell cycle-regulated proteins that peak in either 
G1 or S. In contrast, protein and mRNA abundances are more poorly correlated for proteins that peak 
either in G2&M (r = 0.31) or in G1 and G2&M, that is the G2&M+G1 cluster (r = 0.20). This result is not 
limited to abundances measured in asynchronous cells, as a similar trend is observed when protein and 
mRNA abundances are compared in elutriated cells at specific phases of the cell cycle, as shown in 
Figure 8—figure supplement 2. For example, the correlation coefficient is 0.42 for G2&M-peaking 
proteins in G2&M-phase elutriated cells, as compared with values of 0.67 and 0.73 for G1-peaking 
proteins in G1-phase elutriated cells and S-peaking proteins in S-phase elutriated cells, respectively.
These data show that for cell cycle-regulated proteins, the extent to which protein and mRNA 
abundance correlates is dependent on when during the cell cycle maximum expression occurs. Thus, 
cell cycle-regulated proteins that peak in G2&M and G2&M+G1 are more likely to have poor protein/
mRNA abundance correlation than cell cycle-regulated proteins whose abundance peaks in other 
phases of the cell cycle. These results indicate that mRNA levels are particularly poor predictors of 
protein abundance in the case of cell cycle-regulated proteins whose expression peaks in either G2&M 
or G2&M+G1.
Next, we examined how well the protein and mRNA expression profiles were correlated across 
the elutriated fractions. Mechanistically, these patterns result from the combined effects of differential 
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Figure 8. Correlation of protein and RNA levels across the cell cycle. Log-transformed, iBAQ-scaled protein 
intensities and log-transformed FPKM values (RNA) from asynchronous cells (A) and cell cycle fractions (B). RNASeq 
data are expressed as Fragments Per Kilobase of exon per million fragments Mapped (FPKM), which is a proxy 
for RNA copy number. Histone genes were removed from the analysis due to the absence of poly(A)+ tails in 
histone-encoding messages. Each graph is annotated with the calculated Spearmen correlation coefficients (r).  
(C) Correlation of the protein and mRNA abundances in asynchronous cells of the 358 proteins whose abundances 
are cell cycle regulated (r = 0.45). (D) The same data shown in (C), but split by protein clusters as described 
in Figure 5. (E) Correlation of the expression profiles of the 358 cell cycle regulated proteins and their associated 
transcripts. Genes were classified into two groups based on protein and RNA expression correlation (Pearson’s 
correlation coefficient greater than or equal to 0.5). (F) Cyclin A2 and Cdt1 are examples highlighted from 
the groups in (E). Protein and RNA abundance standard errors were calculated from the variance in scaled 
Figure 8. Continued on next page
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transcriptional, translational, and post-translational regulation of gene expression across the cell cycle. 
Highly concerted protein and mRNA expression levels will typically result from synergistic transcriptional 
and post-transcriptional regulation. Several genes have been previously found to show highly correlated 
protein and mRNA expression across the cell cycle, including A-type cyclins. Consistent with previous 
work in other systems (Pines and Hunter, 1990), we find that Cyclin A2 protein and mRNA expression 
is highly correlated in NB4 cells (Figure 8F, top). Detailed analyzes have documented regulatory 
mechanisms that underlie this correlation: namely, cell cycle-regulated transcription of the cyclin A gene, 
with cyclin A mRNA synthesis being highest in S and G2 (Henglein et al., 1994), and destabilization 
of cyclin A mRNA and protein during early mitosis and G1 (Pines and Hunter, 1990; Glotzer et al., 
1991; Henglein et al., 1994; Dawson et al., 1995; Sudakin et al., 1995). These synergistic regulatory 
mechanisms result in differential expression of the cyclin A gene across the cell cycle. Nearly half of the 
cell cycle-regulated proteins identified in our proteomic data set showed moderate to high correlation 
(r > 0.5) between protein and mRNA expression patterns (Figure 8E). Expression of these genes, like 
cyclin A, may also be controlled by concerted regulatory mechanisms.
In contrast, over half of the proteins whose abundance is shown here to be regulated across the 
cell cycle have low correlation (r < 0.5) between protein and mRNA expression patterns. Cdt1 gene 
expression is even anti-correlated in terms of protein and RNA levels (Figure 8F, bottom). Cdt1 mRNA 
abundance peaks in S-phase, where Cdt1 protein expression is lowest. This surprising inverse relationship 
between protein and mRNA levels is not likely to be due to low data quality for the Cdt1 gene. A high 
correlation (>0.75) is observed among the eight, independently identified peptides used to quantify 
Cdt1 protein expression and error bars indicate the relatively low standard error in scaled intensities 
from the eight supporting peptides. Furthermore, the Cdt1 protein expression pattern across the cell 
cycle is confirmed by immunoblot analyzes of elutriated NB4 cells (Figure 8G), and is consistent with 
what is known in other cell types (Wohlschlegel et al., 2000). Similarly, the Cdt1 mRNA expression pattern 
is reproducibly detected, as indicated by the error bars for mRNA quantitation and is consistent with 
recent reports showing that Cdt1 mRNA levels are high in S-phase due to positive regulation by geminin 
(Ballabeni et al., 2013).
In summary, this study of gene expression in NB4 cells indicates that, even though expression profiles 
for many genes are positively correlated at the transcript and protein level, for a surprisingly large 
fraction of human genes mRNA abundance alone is not a reliable predictor of the corresponding 
abundance of the protein encoded by that mRNA.
Genes whose protein and mRNA abundances are cell cycle regulated 
are coordinately expressed across the cell cycle
From the data described above, we determined that protein and mRNA expression are moderately 
correlated with respect to absolute abundance, that the correlation for bulk gene expression is primarily 
cell cycle independent, but that over half of the proteins identified as cell cycle regulated have discordant 
mRNA expression patterns. Out of the 358 proteins whose abundances are cell cycle regulated, 31 of 
the cognate mRNAs also vary across the elutriated fractions by more than 1.5-fold. Comparison of 
protein and mRNA abundance profiles across the elutriated fractions for these genes reveals highly 
coordinated expression (Figure 9A,B), as measured by the high Pearson correlation coefficient calculated 
for the mean protein and RNA profiles (r = 0.93). For each of these 31 genes, protein, and RNA 
abundances in asynchronous (Figure 9C) and elutriated G1, S, and G2&M cells are also positively 
correlated (r = 0.76, 0.68, 0.79 and 0.84, respectively). These data show that specific subsets of genes 
can be highly coordinately expressed at both the protein and mRNA level.
peptide intensities and biological replicates, respectively. (G) Immunoblot analysis of Cdt1 and GAPDH protein 
expression across asynchronous and elutriated NB4 cells.
DOI: 10.7554/eLife.01630.013
The following figure supplements are available for figure 8:
Figure supplement 1. Analysis of technical and biological variance among duplicates reveals highly reproducible 
RNA quantitation. 
DOI: 10.7554/eLife.01630.014
Figure supplement 2. Correlation of protein and RNA abundances of cell cycle-regulated proteins. 
DOI: 10.7554/eLife.01630.015
Figure 8. Continued
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We note that for genes whose protein and mRNA levels covary across the cell cycle, coordinated 
synthesis of protein and mRNA is likely matched by coordinated protein degradation, as it is known 
that many proteins that are required at high levels in G2&M phase are targeted for degradation by the 
Anaphase Promoting Complex/Cyclosome (APC/C) complex during the late stages of mitosis and G1 
(Amon et al., 1994). Sequence analysis shows that all of these 31 genes contain at least one sequence 
motif that is known to target proteins for degradation by the APC/C (KEN or RxxL), and most (18/31) 
contain both motifs (Figure 9D). Most of these genes (28/31) have been previously annotated in the 
literature as either cell cycle regulated and/or critical for cell cycle progression. Additionally, we 
observe that 26/31 have predicted NF-Y transcription factor binding sites in their promoters (84%), 
which is significantly more frequent than random (p=2.1 × 10−6). The association with NF-Y transcrip-
tion factor binding sites in the promoter region is less frequent for G2&M-peaking cell cycle-regulated 
proteins (∼50%, as shown in Table 1, ∼49% if the 31 co-regulated genes are excluded), though this is 
also higher than random (∼20% across all promoters).
ARHGAP11A is a cell cycle-regulated gene whose protein levels are 
regulated by the APC/C
Among the 31 genes identified whose protein and mRNA abundances are both coordinately cell cycle 
regulated are three genes (ARHGAP11A, ZNF646, and FAM125B) that have not been previously 
annotated as being cell cycle regulated (Figure 9D). We chose to characterize ARHGAP11A further, 
as it was the only gene coding for a protein for which validated antibodies were readily available. 
ARHGAP11A encodes a protein that is predicted to function as a RhoGAP, and has been recently shown to 
be important in regulating formation of the cytokinetic furrow (Zanin et al., 2013). Figure 10A shows the 
MS and RNA-Seq quantitation for ARHGAP11A, indicating that the protein and mRNA abundances 
are lowest in the first elutriated fractions (G1) and peak in the last elutriated fractions (G2&M). These 
Figure 9. Protein and RNA levels are correlated for the specific subset of cell cycle-regulated proteins whose 
cognate mRNA change by 1.5-fold. Of the 358 proteins whose abundances are cell cycle regulated, the cognate 
mRNA of 31 proteins also changes across the elutriated fractions by more than 1.5-fold. Scaled protein (A) and 
mRNA expression profiles (B) are shown as line graphs for these 31 genes, respectively. (C) Comparison of protein 
and mRNA abundances in asynchronous cells reveals a Spearman correlation of 0.76. (D) 27 of the 31 genes have 
predicted NF-Y binding sites in their promoters, and all 31 encode proteins containing a KEN or D-box sequence 
degron. KEN-motifs are especially enriched (>eightfold enrichment, compared to 7% expected by random chance). 
Three genes have not been previously annotated as being cell cycle regulated: FAM125B, ZNF646, ARHGAP11A.
DOI: 10.7554/eLife.01630.016
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cell cycle-dependent changes in ARHGAP11A mRNA abundance are consistent with previous microarray 
studies performed in HeLa cells (Whitfield et al., 2002). The variations in protein levels observed by MS 
were confirmed independently by immunoblot analysis of elutriated lysates (Figure 10B), using a specific 
antibody that was validated by siRNA depletion (Figure 10—figure supplement 1). In contrast, GAPDH 
does not vary in abundance across the elutriated lysates. Thus, the MS and immunoblot data both show 
that ARHGAP11A is a cell cycle-regulated protein whose expression peaks in G2&M and is lowest in G1.
Given that the expression of ARHGAP11A is the lowest in G1 and that the protein sequence contains 
several degrons (one KEN and two D-box motifs), we next tested whether levels of ARHGAP11A protein 
are regulated by the APC/C. The APC/C is a multimeric protein complex whose activity and specificity 
is cell cycle regulated by interactions with co-activating factors Cdh1 and Cdc20 (Visintin et al., 1997). 
Intriguingly, Cdc20 was among the 31 genes identified as being regulated both at the protein and 
mRNA level (Figure 9). Disruption of the APC/C complex, for example by siRNA-mediated depletion 
of Cdh1 and/or Cdc20, is expected to stabilize substrate levels. Thus, we assayed whether ARHGAP11A 
levels are dependent on APC/C activity by immunoblotting lysates from cells where Cdh1 and/or 
Cdc20 have been transiently depleted in both U2OS and RPE-1 cell lines using siRNAs.
U2OS cells were treated with specific siRNAs that target either Cdh1 or Cdc20, mRNA for degradation. 
Transient depletion of both Cdh1 and Cdc20 decreases APC/C activity, as evidenced by a stabilization 
of cyclin B1 protein (Figure 10C), whose levels are known to be regulated by the APC/C (King et al., 
1995). More importantly, disruption of APC/C activity in U2OS cells increases levels of ARHGAP11A 
(Figure 10C). Similarly, transient depletion of Cdh1 in RPE-1 cells resulted in stabilization of the ARHGAP11A 
Figure 10. Identification of ARHGAP11A as a cell cycle regulated protein and a substrate of the APC/C. (A) MS and RNA-Seq quantitation for ARHGAP11A 
protein (left) and mRNA (right), respectively. (B) Immunoblot analysis of ARHGAP11A (HPA antibody) and GAPDH protein expression across asynchronous 
and elutriated NB4 cells. (C) Lysates from U2OS cells treated with either a non-targeting control siRNA (lane 1) or siRNAs targeting Cdh1 and Cdc20 
(lane 2) were probed for levels of ARHGAP11A, Cdh1, Cdc20, cyclin B1, and GAPDH by immunoblot. (D) Asynchronous or serum-starved RPE-1 cells were 
treated with either a non-targeting control siRNA or an siRNA against Cdh1. Lysates were then probed with antibodies against ARHGAP11A (Bethyl 
antibody), Cdh1, cyclin B1, and GAPDH.
DOI: 10.7554/eLife.01630.017
The following figure supplements are available for figure 10:
Figure supplement 1. Validation of anti-ARHGAP11A antibodies by siRNA-based depletion of ARHGAP11A protein. 
DOI: 10.7554/eLife.01630.018
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protein in asynchronous cells (Figure 10D). G1-arrest by serum starvation results in very low levels of 
ARHGAP11A. Transient depletion of Cdh1 results in stabilization of ARHGAP11A, thus showing that 
ARHGAP11A levels are APC/CCdh1-dependent during G1-phase (Figure 10D, lanes 3 and 4). The blots 
were also probed with anti-cyclin B1 antibodies to confirm disruption of APC/C activity (Figure 10D). These 
data independently show that ARHGAP11A levels are lower in G1-phase than in asynchronous RPE-1 cells 
(Figure 10D, lanes 1 and 3), which is consistent with the cell cycle regulation of ARHGAP11A abundance 
observed in elutriated NB4 cells. Thus, we conclude that ARHGAP11A is a cell cycle-regulated protein, 
and that its levels are regulated by targeted degradation mediated by the APC/C.
Data dissemination through the Encyclopedia of Proteome Dynamics
In addition to uploading the raw MS (http://www.ebi.ac.uk/pride/archive/projects/PXD000678) and 
RNA-Seq data files (https://www.ebi.ac.uk/ega/datasets/EGAD00001000736) to public repositories 
(PRIDE and EGA for MS and RNA-Seq data, respectively), we have incorporated the entire analyzed 
protein and RNA data sets from this study into the Encyclopedia of Proteome Dynamics (http://www.
peptracker.com/epd/), a publicly-available, searchable web resource (Larance et al., 2013). The EPD 
aggregates proteomics data from this study on the myeloid cell cycle with our previous large-scale 
studies on protein complexes, subcellular localization and turnover in HeLa and U2OS cells. The EPD 
facilitates cross-correlation and analysis of protein properties across numerous, multidimensional 
proteomics studies. Additionally, for any specific protein, users can quickly retrieve all protein properties 
measured so far by providing a protein identifier, such as a Uniprot ID.
In this study, we highlight as an example the EPD page for cyclin B1 (Figure 11), which displays the 
protein and RNA quantitation across the separate elutriated fractions from this study, and the protein 
abundance bins to which cyclin B1 belongs. Users can also retrieve any previously determined properties 
for this protein, such as putative interaction partners, turnover rate and half-life, subcellular localization 
and estimated abundances in other cell lines.
Discussion
In this study, we have performed a deep proteomic analysis combined with RNA-Seq to obtain a 
global map of gene expression in the human myeloid NB4 cell line. In addition, we have undertaken 
an unbiased re-evaluation of changes in gene expression across the cell cycle at a system-wide level, 
using an experimental strategy designed to cause minimum perturbation to the physiology of cell 
cycle progression in the cells being analyzed. The resulting data set provides one of the most detailed 
descriptions of human gene expression reported to date, including analysis of the regulated expression 
of protein isoforms and phosphorylation sites during the cell cycle. Expression of over 10,000 genes 
was detected at the protein level, with high average sequence coverage (∼38%) and expression of over 
12,000 genes was detected at the mRNA level. For over 6000 genes, high quality data were obtained 
at both the protein and mRNA level in each of six subpopulations of cells that had been differentially 
enriched for cells at distinct cell cycle stages using centrifugal elutriation. We identified 358 proteins 
whose abundance varied by at least twofold in a cell cycle-dependent manner and these genes were 
grouped into seven distinct clusters that showed peak expression at different cell cycle stages.
Overall, this data set, augmented by meta-analysis of other recent high-throughput proteomic 
studies of other human cell lines, provides a new insight into cell identity as characterized by gene 
expression at the protein level. This highlights specific transcription factors and other proteins with 
potential roles in myeloid cell differentiation and function. The data also highlight the very complex 
relationship between the levels of protein and cognate mRNA expression. The protein/mRNA abundance 
relationship varied quite dramatically for different sets of genes and in many cases the level of mRNA 
was found not to be a reliable predictor of protein abundance, indicating an important role for post-
transcriptional mechanisms in the control of myeloid gene expression. To facilitate data sharing and 
community access, all of the data from this study have been collated in the Encyclopedia of Proteome 
Dynamics (http://www.peptracker.com/epd), a searchable online database describing system-wide 
measurements of protein properties (Larance et al., 2013).
In-depth characterization of a minimally perturbed cell cycle
To facilitate analysis specifically of physiologically relevant variations in gene expression across the cell 
cycle, we developed an experimental strategy that avoided the use of synchronization procedures to 
accumulate cells blocked at specific cell cycle stages. In previous studies, this is usually done using 
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either chemical inhibitors or genetic depletion of essential factors, to either activate checkpoints or 
otherwise block progression through the cell cycle, thus allowing a large enough population of cells at 
the same cell cycle stage to be harvested for subsequent biochemical analysis. Although effective, the 
potential disadvantage of these approaches is that they inevitably cause a major metabolic perturbation 
and/or stress to achieve the cell cycle block and this in turn may affect gene expression in ways that 
would not occur during normal cell cycle progression. In addition, to minimize possible effects of 
specialized media on the normal cell cycle, we also avoided here using cell media with dialyzed serum, as 
frequently used for metabolic labeling of cells with heavy isotope substituted amino acids. Consequently, 
we focused on growing cells in normal sera and identified proteins by performing label-free MS analysis 
and we used centrifugal elutriation as the method to generate sub-populations of cells enriched at 
different cell cycle stages.
Centrifugal elutriation is a simple yet effective physical method of enriching for cells at different cell 
cycle phases that is suitable for isolating sufficient quantities of cells for large-scale biochemical analysis 
Figure 11. The Encyclopedia of Proteome Dynamics, a fully searchable, open-access online repository of proteome data. Quantitative protein and RNA 
data from this study are available through the Encyclopedia of Proteome Dynamics (EPD). A screenshot of the EPD is shown, which displays protein and 
mRNA expression profiles across the elutriated fractions, the calculated Pearson correlation coefficient between the protein and mRNA profiles, and 
protein and mRNA abundances in asynchronous cells for cyclin B1 (CCNB1_HUMAN).
DOI: 10.7554/eLife.01630.019
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(Banfalvi, 2008). We used a variety of criteria here, including FACS analysis and immunoblotting, to 
detect multiple known cell cycle-regulated and control proteins, thus validating the successful separa-
tion of NB4 cells into six fractions that were differentially enriched for cells at different cell cycle stages. 
Compared with using metabolic inhibition to block cells at different cell cycle stages, elutriation generates 
minimal stress or disruption of cellular metabolism and physiology. We confirmed that here by showing 
that the elutriated NB4 cells remained viable and continued to grow and proliferate when returned to 
culture post elutriation without showing evidence of changes in morphology. Because the separation 
principle of elutriation is based on physical size, we note that this method can also be used to separate 
cells of different sizes and thus could also be employed to examine changes in either gene expression 
or other processes, associated with cell size variation (Bjorklund et al., 2006; Tzur et al., 2009; 
Navarro et al., 2012).
In combination with centrifugal elutriation, we thus determined both protein and mRNA levels for 
more than 6000 human genes in each of the six, separate elutriated fractions. Analysis of these data 
highlighted examples of three major types of protein cell cycle regulation, that is, changes in protein 
abundance, isoform-specific changes in abundance and changes in protein phosphorylation.
We identified ∼5% of genes as encoding proteins whose abundance varies across the cell cycle by 
at least twofold. These genes formed seven distinct clusters based upon the cell cycle stage where the 
protein showed maximum expression level. As this study represents a re-evaluation of cell cycle-regulated 
gene expression and was not influenced by expectations from the literature, it was reassuring that it 
identified and confirmed so many previously documented cell cycle-regulated factors. In addition, it 
detected novel cell cycle regulated genes and showed that the current gene ontology annotations 
are primarily associated with genes in the clusters showing peak expression at either entry or exit 
from mitosis. However, other clusters show collections of genes that also express proteins whose 
abundance is regulated at other stages of interphase and we propose that these should also be 
annotated in future as ‘cell cycle regulated’ and that this term should not be restricted to genes linked 
with mitosis.
Our analysis of the genes encoding proteins whose abundance is cell cycle-regulated implicates 
several transcription factors as being particularly important for the control of protein expression during 
the cell cycle. For example, in addition to recapitulating the previously described importance of E2F 
transcription factor activity in S-phase (Sherr, 1996), these data also highlight the potentially important 
roles for the NF-Y and STAT3 transcription factors for gene regulation in G2&M and G1&G2, respectively. 
The enrichment of NF-Y binding sites we observed in the promoters of genes encoding proteins that 
peak in the G2&M fraction is consistent with previous reports linking NF-Y transcriptional activity to 
G2&M phase cell cycle functions (Hu et al., 2006).
In comparing our present results with previous data on cell cycle-regulated gene expression in 
human cells, it is interesting that the rather low number of cell cycle-regulated proteins detected 
here in elutriated NB4 cells (∼5%), contrasts with a much higher estimate of ∼40% of the detectable 
proteome varying by at least twofold in abundance across the cell cycle in HeLa cells (Olsen et al., 
2010). This proportion was determined using thymidine- and nocodazole-synchronized HeLa cells and 
is significantly higher than what was reported for HeLa cells synchronized by thymidine alone (∼15%) 
(Lane et al., 2013). The difference in the proportion of cell cycle-regulated proteins observed between 
these studies may be due to technical differences, analysis criteria, growth conditions, the type of 
quantitation employed and/or the synchronization method. Differences between studies performed 
in HeLa and NB4 cells may also reflect tissue-specific and/or cell line-specific plasticity in cell cycle 
regulation in mammalian systems.
Comparison of protein and mRNA expression levels
The data in this study allowed us to examine in detail the relationship between protein and mRNA 
abundance, both in terms of global genomic expression and for specific sets of genes and for cells 
at different stages of cell cycle progression. The results showed that this relationship is remarkably 
complex and clearly indicate that measurements of mRNA levels alone cannot be relied upon to provide 
an accurate reflection of protein abundance in many situations. Indeed, as illustrated for the Cdt1 
gene, we identify examples where protein and mRNA levels are even inversely correlated. The rather 
complex relationship we observe between protein and mRNA levels is important for interpreting 
previous studies that have relied on using either microarray or RNA-Seq data alone as a surrogate for 
reporting on the regulation of protein expression.
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Our data on NB4 cells show that for over 6000 genes protein and mRNA abundances are positively 
correlated, both in asynchronously growing cells and in cells at G1, S, and G2&M phases, though in 
each case with a moderate correlation coefficient of ∼0.63 to 0.65. However, this correlation is weaker 
(0.47) for the ∼5% of genes encoding proteins whose abundance varies across the cell cycle. Interestingly, 
this subset of cell cycle-regulated genes shows further heterogeneity in the relationship between protein 
and mRNA abundance levels when examined more closely to compare the separate clusters of genes 
encoding proteins whose expression peaks at different stages. Thus, we observe dramatically varying 
correlations in protein/mRNA abundance levels in different clusters (Figure 8). This ranges from the 
very low value of ∼0.2 (‘G2&M+G1’-peaking proteins, cluster 4), up to the higher than average value 
of ∼0.69 for proteins with peak abundance in S phase (cluster 2).
Transcriptional and post-transcriptional regulation
The NB4 cell data show that a subset of the genes that encode proteins whose abundance is cell cycle 
regulated is concordantly expressed at the protein and mRNA level. This is the case particularly for 
genes encoding proteins whose abundance peaks in either S or in the G2&M phases of the cell cycle. 
This suggests that transcriptional regulation mechanisms contribute significantly to modulating protein 
expression levels in these phases, but less so in G1. A likely explanation for this observation, consistent 
with the literature on cell cycle regulatory mechanisms, is that post-transcriptional controls, including 
targeted protein degradation and regulation of translation, operate differentially across the cell cycle 
and cause temporal imbalances in the relation between transcript levels and proteins. It is well known 
that mechanisms exist for controlling the targeted degradation of specific proteins, for example, based 
on the substrate-specific action of E3 ligases targeting proteins for degradation by the proteasome 
(King et al., 1996).
A number of cell cycle-regulated proteins have been shown to be targeted for degradation at specific 
cell cycle stages, as exemplified by mechanisms such as the degradation of proteins by the APC/C at 
the end of mitosis and into G1 phase (King et al., 1996; Reed, 2003; Pines, 2011). Indeed, recent 
high-throughput studies of protein turnover in HeLa and U2OS cells demonstrated that the most rapidly 
degraded group of proteins were strongly associated with the GO terms ‘cell cycle’ and ‘mitosis’ 
(Boisvert et al., 2012; Larance et al., 2013). In this study, we identify many known cell cycle-regulated 
APC/C substrates, including aurora kinases (Honda et al., 2000) and securin (Zur and Brandeis, 2001). 
In addition, we validated here a novel cell cycle-regulated protein (ARHGAP11A), whose regulation is 
mediated by targeted degradation by the APC/C.
In addition to the APC/C, whose activity is restricted to mitosis and G1, there are other complexes 
that target proteins for degradation in other phases of the cell cycle. For example, the SCFSkp2 complex 
targets proteins for degradation during and at the entry of S-phase. Substrates include Cdt1 (Wohlschlegel 
et al., 2000), which is critical for replication origin licensing and Cep192, whose hydroxyproline-modified 
form is targeted for degradation by the SCFSkp2 complex (Moser et al., 2013). We note that the cluster-
ing analysis identified a subset of NB4 proteins whose abundances are similarly regulated across the 
cell cycle as Cdt1 (Figure 5, cluster 7). Proteins with Cdt1-like expression patterns may be similarly 
regulated by SCFSkp2; however, additional experiments are required to test these hypotheses.
In contrast with the extensive literature on cell cycle-regulated protein degradation, studies 
examining translational control across the cell cycle, particularly high-throughput studies, are few in 
number. However, a recent study using puromycin-analogs and in vitro immunoprecipitation in thymidine-
synchronized HeLa cells revealed that a subset of the proteome (339/4984 proteins) is differentially 
translated across the cell cycle, while the translation of most proteins remains relatively constant 
(Aviner et al., 2013). Interestingly, these authors propose that mRNA translation is particularly important 
in regulating G2&M-associated proteins. It will be interesting in future to examine the contribution of 
translational regulation mechanisms to the cell cycle variations in protein abundance measured here in 
NB4 cells.
In-depth characterization of a myeloid leukemia proteome
We have shown that the use of a dual protease digestion strategy combined with extensive prefractiona-
tion of isolated peptides by strong anion exchange-enabled proteomic characterization of a leukemia 
cell line to a depth of over 10,000 proteins, identified with on average 15 peptides per protein and 
with high sequence coverage (mean ∼38%). To the best of our knowledge, this data set, together with 
the accompanying RNA-Seq data, provides the most comprehensive study to date of gene expression in 
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human myeloid cells. The depth of proteome sequence coverage is comparable with, if not exceeding, 
the proteome coverage obtained in recent deep proteome studies performed on other human tumor 
cell lines, including epithelial tumor cell lines such as HeLa and U2OS. The proteomic workflow is not 
exclusive to either suspension cells or leukemia cell lines and, based on current technology and instru-
mentation, is applicable in principle to any cell type where ∼200 μg of protein can be isolated.
The high protein sequence coverage obtained was shown to be particularly helpful for allowing a 
more detailed comparison of gene expression and regulation at the level of separate protein isoforms. 
Importantly, using the information from the high number of independent peptide identifications per 
protein group, we could show clear examples where genes encoded multiple isoforms, only a subset 
of which were cell cycle regulated in their expression pattern. This also showed that aggregating all of 
the peptide information and interpreting it in terms of the behavior of a single hypothetical polypep-
tide, as typically done in proteomic studies, would lead to an incorrect conclusion that the corre-
sponding gene was not subject to cell cycle regulation because the peptide information for the cell 
cycle-regulated isoform was diluted by the contribution of the peptides shared with the other, unregulated 
isoforms encoded by the same gene.
We infer that our current data underestimate the total number of polypeptides whose abundance 
is cell cycle regulated, not only because we lack combined protein and mRNA data across the full cell cycle 
for at least 4000 additional genes whose expression was detected in the asynchronous NB4 cell popula-
tions, but also because we lack sufficient numbers of peptides to be confident that we are efficiently 
detecting and quantifying most of the separate protein isoforms that are expressed. Our data therefore 
highlight the need for further technological development in proteomics methods and instrumentation 
because even in the deepest analyzes reported to date, as with this present study, still less than 50% of the 
total protein sequence is identified for the genes we can detect being expressed at the protein level. It is 
also difficult to detect multiple peptides consistently across every sample in a complex experiment, as is 
the case here with multiple elutriated cell populations. Nonetheless, we anticipate that continued improve-
ments in instrumentation, combined with improved sample preparation, will provide additional sequencing 
depth and speed in the future and the present study illustrates how this can be used to produce a more 
comprehensive mapping of gene expression and regulation during fundamental biological processes.
Towards a proteomic definition of cell identity
A meta-analysis of the data from human cell lines where the most detailed proteomic information is 
available revealed a set of proteins whose expression was only detected here in NB4 cells. This NB4-
specific protein set was enriched for transcription factors, including proteins that are already known to 
be important for myeloid cell differentiation, such as PU.1 and C/EBPα/δ (Orkin and Zon, 2008). We also 
identified a core set of proteins that were detected in myeloid-derived cell lines (K562 and NB4), but not 
in other cell lines, most of which are non-leukemic and from epithelial origin. Many genes encoding these 
proteins are overexpressed at the mRNA level in normal blood, leukemia, and lymphoma cells compared 
to other normal and tumor tissues in the Broad Global Cancer Map (Figure 12) (Subramanian et al., 
2005), and are enriched in genes that are overexpressed in leukemia/lymphoblastic tissues in the Novartis 
GNF tissue expression database (25/87 genes, p=0.00059) (Su et al., 2002). The proteomic data here 
provide direct evidence that many of the overexpressed mRNAs observed are translated into protein 
and that these proteins are likely overexpressed in cancer cells of the myeloid lineage compared to 
cancer cells derived from other tissues. For comparison, HeLa-specific genes were similarly analyzed 
and found to be overexpressed in normal uterine tissue and prostate tumors (Figure 12). Given the 
high variance observed between mRNA and protein abundance, we note that direct experimental 
evidence of protein overexpression has added benefits to clinical pathology and diagnostics.
Proteomic approach to gene regulation
Gene regulation that extends to the protein level, including cell cycle-dependent regulation, broadly, 
encompasses the modulation of any properties of proteins and protein isoforms and not just variations 
in protein abundance, as we have focused on in this study. A more comprehensive analysis of cell cycle 
regulation of gene expression should thus in future be extended to analyze also variations in the 
subcellular localization of the proteome, changes in protein complex formation and protein–protein 
interactions and a more detailed description of protein isoform expression and post-translational protein 
modifications. Methods are now emerging that should allow the systematic and quantitative analysis 
of these varied properties at a system-wide level. It will be important also to repeat such in depth 
Biochemistry | Cell biology
Ly et al. eLife 2014;3:e01630. DOI: 10.7554/eLife.01630 26 of 36
Research article
studies on gene expression across a wide range of cell types, particularly also in primary cells, to eval-
uate what types of mechanisms are used ubiquitously and which are used in conjunction with specific 
needs of specialized cell types and/or modified by the process of cell transformation and influenced 
by oncogene expression. It will also be interesting to compare the results of cell cycle-regulated gene 
expression detected here using centrifugal elutriation to separate cells into distinct populations 
enriched at different cell cycle stages with comparable analysis of cells, where cell cycle progression is 
blocked with inhibitors to compare what effect such metabolic perturbations may have on gene 
expression, separate to the normal control of the cell cycle.
We have collated all of the data from this study into the Encyclopedia of Proteome Dynamics, a 
searchable online database (http://www.peptracker.com/epd). The data here are combined with other 
high-throughput studies of protein properties in HeLa and U2OS cells, including the system-wide 
analysis of protein turnover and protein degradation rates in separate subcellular compartments and the 
analysis of native, multi-protein complexes separated by size exclusion chromatography (Ahmad et al., 
2012; Boisvert et al., 2012; Kirkwood et al., 2013; Larance et al., 2013). In common with this present 
study, all of these data show the importance of moving beyond simple protein identification to a more 
detailed analysis of complex proteome dynamics, including the analysis of selective regulation of distinct 
protein isoforms and post-translational modifications for deciphering cellular regulation mechanisms. 
Furthermore, the combining of highly annotated large data sets in this format not only adds value 
through sharing of information with the community, it also facilitates a Super-Experiment approach 
(Boulon et al., 2010). Here, the value of each individual data set is enhanced by allowing the detailed 
cross-comparison and analysis of protein behavior and responses between different cell types and under 
different growth conditions. We suggest that this provides a useful model that could be extended in 
future to provide a resource incorporating data generated at a community wide level.
Materials and methods
Cell culture and counterflow centrifugal elutriation
The NB4 cell line was established from long-term cultures of acute myeloid leukemia blast cells grown 
on bone-marrow stromal fibroblasts (Lanotte, 1991). NB4 cells were obtained from the Hay laboratory 
Figure 12. Many cell-line specific genes are overexpressed in tumors and normal tissues that are associated with 
the developmental origin of the cell line. mRNA expression heatmaps from the Broad Global Cancer Map for 
NB4- and K562- specific genes (left) and HeLa-specific genes (right). Each heatmap has tissue along the horizontal 
axis and gene along the vertical axis. Vertical red streaks indicate that many genes are similarly overexpressed in a 
particular tissue. Many NB4- and K562-specific genes are overexpressed in lymphoid, leukemia, and normal 
hematopoietic tissues, whereas HeLa-specific genes are overexpressed in normal uterine tissues and prostate tumors.
DOI: 10.7554/eLife.01630.020
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(University of Dundee). The cells were cultured at 37°C in the presence of 5% CO2 as a suspension 
in RPMI-1640 (Life Technologies, United Kingdom) supplemented with 2 mM L-glutamine, 10% 
vol/vol fetal bovine serum (FBS, Life Technologies), 100 units/ml penicillin and 100 μg/ml strepto-
mycin (100X stock, Life Technologies). Cell cultures were maintained at densities between 1 × 105 and 
1 × 106 cells/ml and harvested by centrifugation when cultures reached ∼8 × 105 cells/ml.
Pellets containing ∼5 × 108 cells were resuspended in 5 ml elutriation buffer (PBS +1% FBS). The 
resulting cell suspension was passed through a 19G-needle three times to disaggregate cell clumps 
and then loaded into a Beckman counterflow centrifugal elutriator (Beckman JE-5.0/JE), equipped 
with a standard elutriation chamber and a Cole–Parmer MasterFlex Model 900-292 peristaltic pump. 
The centrifuge was operated at 1800 rpm and the flow rate was initially set to 16.68 ml min−1. After 
cells have been loaded into the elutriation chamber, 50 ml fractions were collected at the following 
flow rates: 21.18, 23.88, 25.68, 27.47, 29.27, and 38.27 ml min−1 (i.e., fractions 1 through 7). A 2 ml 
aliquot containing a minimum of 5 × 105 cells from each fraction was reserved for flow cytometry. The 
remaining cells were harvested for protein and RNA extraction.
Cell yields range from >8 × 107 cells (Fraction 1, G1) to 2 × 106 cells (Fraction 6, G2&M), which 
reflect the typical cell cycle phase distribution found in cultured cell lines. Fraction 6, which yields the 
lowest cell number, still provides ∼1.0 mg of total protein, which is sufficient for in-depth proteomics 
analysis using current technology (min ∼200 μg).
Single Shot (SS) proteomics sample preparation
For protein extraction, NB4 cells were pelleted, washed twice with cold PBS and then lysed in 0.3–1.0 ml 
HES lysis buffer (2% SDS, 10 mM HEPES pH 7.4, 1 mM EDTA, 250 mM sucrose, Roche protease 
inhibitors, Roche PhosStop; UK). Lysates were heated to 95°C for 10 min and homogenized using 
Qiashredder (Qiagen). 200 μg of the lysate was further processed for LC-MS/MS analysis using a 
modification of the FASP protocol (Wisniewski et al., 2009). Briefly, lysates were loaded onto pre-
equilibrated 30 kD-cutoff spin columns (Sartorius UK) and washed twice using denaturing urea buffer 
(8 M urea, 10 mM Tris, pH 7.4). Proteins were reduced with TCEP (25 mM in denaturing urea buffer), 
for 15 min at room temperature and alkylated with iodoacetamide (55 mM in denaturing urea buffer), in 
the dark for 45 min at room temperature. Lysates were then buffer-exchanged into 0.1 M triethylam-
monium bicarbonate, pH 8.5 (TEAB, Sigma) and digested with trypsin (1:50, Promega UK) overnight 
at 37°C. Digestion efficiency was checked by SDS-PAGE analysis and protein staining with SimplyBlue 
SafeStain (Life Technologies). After collecting the first peptide flow-through, the spin column was 
washed twice with 0.1 M TEAB, then twice with 0.5 M NaCl. The flow-through and washes were 
combined and desalted using SepPak-C18 SPE cartridges (Waters UK). Peptides were then dried and 
resuspended in 5% formic acid for LC-MS/MS analysis.
Strong anion exchange (SAX) proteomics sample preparation
For protein extraction, NB4 cells were pelleted, washed twice with cold PBS and then lysed in 0.3–1.0 ml 
urea lysis buffer (8 M urea, 100 mM Tris pH 7.4, Roche protease inhibitors, Roche PhosStop). Lysates 
were vigorously mixed for 30 min at room temperature and homogenized using a Branson Digital 
Sonifier (30% power, 30 s). Proteins were reduced with TCEP (25 mM in denaturing urea buffer), for 15 min 
at room temperature and alkylated with iodoacetamide (55 mM in denaturing urea buffer), in the dark 
for 45 min at room temperature. Lysates were diluted with digest buffer (100 mM Tris pH 8.0 + 1 mM 
CaCl2) to reach 4 M urea, and then digested with 1:50 Lys-C (Wako Chemicals, Japan) overnight at 
37°C. The digest was then split into two fractions. The first was retained as the Lys-C digest, which 
was shown previously to produce peptides that are complementary to trypsin (Swaney et al., 2010). 
The second was diluted with digest buffer to reach 0.8 M urea and double-digested with trypsin 
(Promega; 1:50). Digest efficiencies were checked by SDS-PAGE analysis and protein staining. The 
digests were then desalted using SepPak-C18 SPE cartridges, dried, and resuspended in 50 mM 
borate, pH 9.3. Peptides were separated onto a Dionex Ultimate 3000 HPLC system equipped with an 
AS24 strong anion exchange column, using a similar protocol to the hSAX method described previ-
ously (Ritorto et al., 2013). Peptides were chromatographed using a borate buffer system, namely 10 
mM sodium borate, pH 9.3 (Buffer A) and 10 mM sodium borate, pH 9.3 + 0.5 M sodium chloride 
(Buffer B) and eluted using an exponential elution gradient into 12 × 750 μl fractions. The peptide 
fractions were desalted using SepPak-C18 SPE plates and then resuspended in 5% formic acid for 
LC-MS/MS analysis.
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Liquid chromatography mass spectrometry analysis (LC-MS/MS)
For tryptic digests, including tryptic + Lys-C double digests, peptide chromatography was performed 
using a Dionex RSLCnano HPLC. Peptides were loaded onto a 0.3 mm id × 5 mm PepMap-C18 pre-
column and chromatographed on a 75 μm × 15 cm PepMap-C18 column using the following mobile 
phases: 2% acetonitrile +0.1% formic acid (Solvent A) and 80% acetonitrile +0.1% formic acid (Solvent 
B). The linear gradient began with 5% B to 35% B over 156 min with a constant flow of 300 nl/min. The 
peptide eluent flowed into a nanoelectrospray emitter at the front end of a Velos Orbitrap mass 
spectrometer (Thermo Fisher, San Jose, CA). A typical ‘Top15’ acquisition method was used. Briefly, the 
primary mass spectrometry scan (MS1) was performed in the Oribtrap at 60,000 resolution. Then, the top 
10 most abundant m/z signals were chosen from the primary scan for collision-induced dissociation and 
MS2 analysis in the Orbitrap mass analyzer at 17,500 resolution. Precursor ion charge state screening 
was enabled and all unassigned charge states, as well as singly charged species, were rejected.
For Lys-C digests, peptide chromatography was also performed using a Dionex RSLCnano HPLC. 
Peptides were directly injected onto a 75 μm × 50 cm PepMap-C18 column using the following mobile 
phases: 2% acetonitrile +0.1% formic acid (Solvent A) and 80% acetonitrile +0.1% formic acid (Solvent 
B). The linear gradient began with 5% B to 35% B over 220 min with a constant flow rate of 200 nl/min. 
The peptide eluent flowed into a nanoelectrospray emitter at the front end of a Q-Exactive (quadrupole 
Orbitrap) mass spectrometer (Thermo Fisher). A typical ‘Top10’ acquisition method was used. Briefly, the 
primary mass spectrometry scan (MS1) was performed in the Oribtrap at 70,000 resolution. Then, the top 
10 most abundant m/z signals were chosen from the primary scan for collision-induced dissociation in 
the HCD cell and MS2 analysis in the Orbitrap at 17,500 resolution. Precursor ion charge state screening 
was enabled and all unassigned charge states, as well as singly charged species, were rejected.
RNA extraction and RNA-Seq
NB4 cell pellets from elutriation were resuspended in 0.25 ml PBS and immediately lysed by addition 
of 0.75 ml Trizol LS (Sigma, United Kingdom). RNA extraction was then performed according to manu-
facturer’s instructions. Extracted RNA was resuspended in nuclease-free water and quantified by fluo-
rometry using the RNA Qubit assay (Life Technologies). Fractions with similar cell cycle phase profiles 
were combined to produce samples enriched in G1 (fractions 1 + 2), S (fractions 3 + 4), and G2&M 
(fractions 5 + 6) RNA. The integrity of the total RNA was assessed using an Agilent Bioanalyser.
Two biological replicates were analyzed in technical duplicate by standard Illumina RNA-Seq. Briefly, 
mRNA was extracted using oligo dT beads, fragmented, then reverse transcribed using random hexamers. 
The cDNA was then sequenced using paired ends reads at a length of 75 bp. Each sample was run on 
a single lane of an Illumina HiSeq, to improve coverage of lower abundance transcripts.
A suite of custom scripts was designed to evaluate the quality of the resultant RNA-Seq data. 
Briefly, the data were evaluated for standard sequencing metrics including GC content and percent 
of reads with a quality score either greater or equal to 30. RNA-Seq specific effects were scrutinized 
including evenness of coverage across the transcriptome, absence of significant 3’ bias, successful 
reduction of ribosomal RNA and high complexity of the sequenced fragments (determined by unique 
start and end positions of the insert).
The paired-end RNA-Seq data were then aligned to the human genome (build hg19), using TopHat, 
without providing a gene reference (to avoid forced mappings). Following duplicate removal using 
Picard’s MarkDuplicate (http://picard.sourceforge.net), we quantified the gene expression of known 
protein coding genes using Cufflinks (Trapnell et al., 2013).
siRNA depletion experiments
Depletion of Cdc20 and Cdh1/Fzr1 utilized pools of four siRNAs at a final, total concentration of 
20 nM (Dharmacon). Lipofectamine RNAiMax (Life technologies) transfection reagent was used according 
to manufacturer’s recommendations. Negative control (firefly luciferase) siRNA sequence is: 5′CGUACGC
GGAAUACUUCGA. Cdc20 siRNA sequences are: 5′CGGAAGACCUGCCGUUACA, 5′GCAGAAACGG
CUUCGAAAU, 5′GGGCCGAACUCCUGGCAAA, 5′GCACAGUUCGCGUUCGAGA. The lamin A/C 
siRNA sequence is 5′CUGGACUUCCAGAAGAACA. Cdh1/Fzr1 siRNA sequences are identical to those 
used in previous studies (Emanuele et al., 2011). Depletion of ARHGAP11A utilized pools of four siRNAs 
at a final, total concentration of 20 nM, unless otherwise specified (sequences: 5′UACAGACUCUUAU
CGAUUA, 5′GUUCGAAGAUCUCUGCGUU, 5′GGUAUCAGUUCACAUCGAU, 5′AAGCGAUCAUUG
CCAGUAG).
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hTERT-RPE1 cells were harvested 24 hr post transfection for asynchronous populations. For G1 
populations, hTERT-RPE1 cells were changed into serum free medium 24 hr post transfection and 
harvested 24 hr after that (48 hr post transfection). U2OS cells were transfected with siRNA pools 
targeting both Cdc20 and Cdh1 and harvested 24 hr later. Lysates were separated by SDS-PAGE, 
transferred to nitrocellulose membranes and immunoblotted using antibodies recognizing either 
GAPDH (sc-25778; Santa Cruz, USA), Cdh1 (ab3242; Abcam) or ARHGAP11A (HPA040419; Sigma UK 
and A303-097A; Bethyl USA) following standard procedures.
Flow cytometry and immunoblotting of elutriated NB4 lysates
NB4 cells (5 × 105 cells, minimum) were resuspended in cold 70% ethanol and fixed at room temperature 
for 30 min. The fixed cells were then washed twice with PBS and resuspended in PI stain solution (50 μg/ml 
propidium iodide and 100 μg/ml ribonuclease A in PBS). The cells were incubated in PI stain solution 
for 30 min and then analyzed by flow cytometry on a FACScalibur (BD Biosciences UK). An asynchronous 
population of cells was used as a control to adjust flow cytometer settings, which then remained constant 
throughout analysis of the set of elutriated fractions. The flow cytometry data were analyzed using FlowJo 
(Tree Star, Inc., OR, USA).
Lysates for SDS-PAGE analysis were prepared in lithium dodecylsulfate sample buffer (Life 
Technologies) and 25 mM TCEP. Samples were heated to 65°C for 5 min and then loaded onto a 
NuPage BisTris 4–12% gradient gel (Life Technologies), in either MOPS or MES buffer. Proteins were 
electrophoresed and then transferred to nitrocellulose membranes using program 3 (7 min) on the 
iBlot dry blotting system (Life Technologies). Membranes were then blocked in 3% milk in immunoblot 
wash buffer (TBS +0.1% Tween-20) for 1 hr at room temperature. Membranes were then probed with 
primary antibody overnight at 4°C, washed and then re-probed with HRP-conjugated secondary anti-
body. Primary antibodies for cell cycle immunoblot analysis were obtained from BD Biosciences (aurora 
kinase B), Atlas Antibodies (ARHGAP11A, HPA040830) and from Cell Signaling Technology (cyclin B1, 
cyclin A2, cyclin E, phospho-Histone H3-S10). Bands were visualized using enhanced chemilumines-
cence (Millipore Immobilon UK) and CCD camera detection (FujiFilm LAS-4000 system).
Data analysis
The RAW data files produced by the mass spectrometer were analyzed using the quantitative prote-
omics software MaxQuant, version 1.3.0.5 (Cox and Mann, 2008). This version of MaxQuant includes 
an integrated search engine, Andromeda (Cox et al., 2011). The database supplied to the search 
engine for peptide identifications was a UniProt human protein database (‘Human Reference Proteome’ 
retrieved on 19 August 2012) combined with a commonly observed contaminants list. The initial mass 
tolerance was set to 7 p.p.m. and MS/MS mass tolerance was 0.5 Da. Enzyme was set to trypsin/P with 
up to 2 missed cleavages. Deamidation, oxidation of methionine and Gln->pyro-Glu were searched as 
variable modifications. Identification was set to a false discovery rate of 1%. To achieve reliable identi-
fications, all proteins were accepted based on the criteria that the number of forward hits in the data-
base was at least 100-fold higher than the number of reverse database hits, thus resulting in a false 
discovery rate of less than 1%. Protein isoforms and proteins that cannot be distinguished based on 
the peptides identified are grouped by MaxQuant and displayed on a single line with multiple UniProt 
identifiers. The label free quantitation (LFQ) algorithm in MaxQuant was used for protein quantitation. 
The algorithm has been previously described (Luber et al., 2010). The MaxQuant data analysis was 
repeated with searches for the following post-translational modifications: Phospho(STY), Methyl/
Di-Methyl (KR), and Acetyl (K). Protein quantitation was performed on unmodified peptides and peptides 
that have modifications that are known to occur during sample processing (pyro-Glu, deamidation). All 
resulting MS data were integrated and managed using Data Manager, a laboratory information 
management system (LIMS) that is part of the PepTracker software platform (http://www.PepTracker.com).
The downstream data interpretation (protein and RNA data) of cell cycle stages in this study was 
performed primarily using the R language (version 0.95.262). An initial cleaning step was performed to 
improve the quality and value of the data set. This step involved removing proteins with less than 2 peptide 
identifications, those labeled as either contaminants or reverse hits and those where data were missing 
in any of the fractions. Proteins were further filtered using a procedure analogous to a ‘checksum’ 
function in computing. An algorithm was constructed to assess the self-consistency of the quantitation 
based on known relationships between the elutriated fractions. The intensities measured in the 
asynchronous NB4 cell population can thus be modeled as a linear combination of the intensities 
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originating from the six elutriated fractions that have been normalized by the measured cell count in 
each elutriated fraction. For each protein, the theoretical linear combination of elutriated fraction 
intensities (scaled by cell number) should match the protein intensity measured experimentally in the 
asynchronous population. Similar factors were calculated between adjacent fractions (e.g., F1 vs F2), 
using cell number and the proportions of cells in each phase, as determined by flow cytometry. These 
stringent criteria left a subset of the total proteins detected with very high data coverage across the 
six elutriated cell cycle fractions and high self-consistency in quantitation.
Absolute protein abundances were estimated using the iBAQ algorithm, as previously described 
(Schwanhausser et al., 2011). Gene ontology analysis was performed using the DAVID web resource 
(Huang da et al., 2009) and STRING (Jensen et al., 2009). Predicted transcription factor binding sites 
were retrieved from MSigDB (Subramanian et al., 2005; Matys et al., 2006). Tissue mRNA expression 
data were obtained from the Broad Cancer Map, as implemented in MSigDB (Ramaswamy et al., 
2001; Subramanian et al., 2005). An arbitrary twofold cutoff was implemented to identify cell cycle 
varying proteins. Proteins were then clustered using the Ward algorithm into 16 clusters. 15 of these 
clusters were then re-clustered based on the phase of maximum expression. The final cluster, which 
had two peaks across the cell cycle fractions, was left unchanged (i.e., the G2&M+G1 cluster). A similar 
clustering analysis was performed for phosphopeptide intensities.
To carry out isoform analysis, the MaxQuant data were re-analyzed to produce isoform-specific cell 
cycle profiles. To do this the MS/MS information from the peptide evidences (evidence.txt), in the 
MaxQuant output, was used to determine the number of unique MS/MS counts in each fraction. These 
MS/MS counts were then averaged for peptides belonging to the same isoform, providing an isoform 
specific profile of MS/MS counts across fractions. This process was carried out with the additional 
quality filters described above, that is removal of contaminant and reverse hits and ensuring isoforms 
have a minimum of two unique peptide identifications. To highlight potentially interesting isoforms 
displaying differential behavior, a correlation score was calculated between isoforms of the same 
protein. Proteins showing a poor correlation between isoforms were used to identify examples of 
differentially regulated isoforms across the cell cycle fractions.
To compare protein and RNA data, protein identifiers were mapped to Ensembl Gene ID. Histone 
genes were removed from this data analysis, due to their lack of poly(A) tails. Absolute protein and 
mRNA abundances were plotted in DataShop, a data visualization tool developed as part of the 
PepTracker software suite (www.PepTracker.com). The PepTracker app runs on both Windows and 
Mac OSX and is freely available for download (www.PepTracker.com/ds/).
Data sharing
Gene expression data sets are provided in multiple forms to facilitate access for a range of end-users. MS 
raw files can be accessed from the EBI PRIDE database (accession PXD000678). RNA-Seq raw files will 
be available from EBI (accession EGAD00001000736). Peptide evidence data derived from MaxQuant 
have been deposited to Dryad and can be accessed using this hyperlink: http://dx.doi.org/10.5061/
dryad.2r79qL (Ly et al., 2014). Protein, phosphoprotein, and RNA identifications and quantitations are 
available in supplementary tables to this manuscript (e.g., Supplementary files 1, 4 and 6). Outputs 
from the cell cycle gene expression analysis, cell line meta-analysis, and comparative protein and mRNA 
analysis are also provided in supplementary tables (Supplementary files 2, 3, and 5).
In addition, gene-by-gene visualization of the quality-filtered data set of protein and mRNA expression 
for over 6000 genes analyzed across the cell cycle is provided in a searchable, online format via the 
Encyclopedia of Proteome Dynamics (EPD) (http://www.peptracker.com/epd) (Larance et al., 2013). 
This is a web-based tool, part of the PepTracker platform, which aims to visually communicate and 
disseminate data from large scale, multi-dimensional proteomic experiments. The EPD is developed 
using Python and the Django web framework. The EPD uses an Oracle database to store raw data, 
including the protein and mRNA data from this study. The visualizations depicting protein and RNA data 
are created using the R programming language and integrated into the web tool via the RPy2 library.
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Additional files
Supplementary files
• Supplementary file 1. Proteomics data set. This file summarizes the proteins identified and quantified 
in asynchronous NB4 cells and in the fractions produced by elutriation, and includes the following data 
for each protein identification: protein and gene identifiers, protein descriptions, sequence coverage, 
the number of supporting peptides, the posterior error probabilities (PEPs), the extracted ion 
chromatogram (XIC) intensities, the LFQ-normalized intensities, the iBAQ-scaled intensities, and 
mapped transcript FPKM values from the RNA-Seq data.
DOI: 10.7554/eLife.01630.021
• Supplementary file 2. Cell line proteome meta-analysis. Comparison of the proteomic data set 
obtained for NB4, a human promyelocytic leukemia cell line that grows in suspension culture, with 
other recent examples of in depth proteomic analysis of different human cell lines, most of which are 
adherent tumor cell lines of either fibroblast or epithelial origin. In total, the meta-analysis included 
protein data from 14 cell line proteomes: 3 × HeLa, 2 × U2OS, A549, GAMG, HEK293, K562, LnCap, 
MCF7, RKO, HepG2, and Jurkat-T (Lundberg et al., 2010; Beck et al., 2011; Nagaraj et al., 2011; 
Geiger et al., 2012), which were consolidated and mapped to Ensembl Genes prior to comparison. 
The combined data set provides evidence of protein-level expression of over 11,000 genes. Of these, 
a common set of ∼3000 genes are identified by protein data from all these cell lines, defining a core, 
shared proteome (Columns D and E), and >1000 genes are uniquely detected in this analysis of 
NB4 cells (Columns A and B). A focused comparison of NB4, K562, Jurkat-T, HeLa and MCF7 cell line 
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proteomes reveals ∼90 genes that are specifically expressed in myeloid cell lines NB4 and K562 
(Columns G and H).
DOI: 10.7554/eLife.01630.022
• Supplementary file 3. Proteins whose Abundance is cell cycle regulated. For quantitation, the proteomic 
data set was filtered to only include proteins that were detected in asynchronous cells and all six 
elutriation fractions. Of these ∼6500 proteins, 358 (∼5.5%) are proteins whose abundance is cell cycle 
regulated (i.e., varies in abundance by at least two-fold across the fractions). These proteins vary in 
expression profile, and cluster into seven distinct groups that differ primarily in peak fraction. Gene and 
protein identifiers, cluster membership, and motifs that are predicted to modulate post-translational 
regulation are provided below. Other than the Dbox (R-x-x-L from King et. al, Mol. Biol. Cell 1996, 7, 
1343-1357), motif sequences were obtained from the Eukaryotic Linear Motif resource (ELM).
DOI: 10.7554/eLife.01630.023
• Supplementary file 4. Phosphopeptide dataset. This file summarizes the ∼2700 phosphopeptides 
identified and quantified in asynchronous NB4 cells and in the fractions produced by elutriation, and 
includes the following data for each phosphopeptide identification: protein and gene identifiers, 
protein descriptions, the phosphopeptide sequence, localization scores and probabilities, posterior error 
probabilities (PEPs), the Andromeda search scores, the mass error, and the extracted ion chromatogram 
(XIC) intensity.
DOI: 10.7554/eLife.01630.024
• Supplementary file 5. Proteins whose phosphorylation is cell cycle regulated. This file summarizes the 
cell cycle varying phosphopeptides that were identified without phospho-specific enrichment. These 
phosphosites were filtered to only include phosphopeptides that were independently identified 
in asynchronous cells and in all elutriation fractions. A minor fraction of these phosphopeptides (89 
phosphopeptides, or 3% of the total phosphopeptides identified in this data set, corresponding to 
79 phosphoproteins) vary by at least two-fold across the elutriation fractions. Cell cycle regulated 
phosphopeptides are listed below with Andromeda database search scores, localization probabilities, 
posterior error probabilities (PEPs), and intensities in each fraction.
DOI: 10.7554/eLife.01630.025
• Supplementary file 6. RNA-Seq data set. This file provides gene identifiers, counts, and data quality 
markers for protein coding genes identified in any of the elutriated samples. The six elutriated fractions 
were pooled into three samples (F1+F2, F3+F4, F5+F6). mRNA was then separately extracted from 
these pooled samples using oligo dT beads, fragmented, then reverse transcribed using random 
hexamers. The cDNA was then sequenced using paired ends reads at a length of 75 bp. Each sample 
was run on a single lane of an Illumina HiSeq, to improve coverage of lower abundance transcripts. The 
paired-end RNA-Seq data were then aligned to the human genome (build hg19), using TopHat, 
without providing a gene reference (to avoid forced mappings). Following duplicate removal using 
Picard’s MarkDuplicate (http://picard.sourceforge.net), we quantified the gene expression of known 
protein coding genes using Cufflinks (Trapnell et al., 2013). Genes with low data quality were removed 
from subsequent data analysis.
DOI: 10.7554/eLife.01630.026
Major datasets
The following datasets were generated:
Author(s) Year Dataset title Dataset ID and/or URL
Database, license, and accessibility 
information
Ly T, Ahmad Y,  
Shlien A, Soroka D, 
Mills A, Emanuele MJ, 
Stratton MR,  
Lamond AI
2014 Peptide 
Evidence
http://dx.doi.org/ 
10.5061/dryad.2r79q
Publicly available at Dryad (http://
datadryad.org/). This compressed file 
contains a tab-delimited table listing the 
peptide evidence generated by pro-
cessing the raw MS and MS/MS data using 
the MaxQuant software package, which 
includes a built-in database search engine 
called Andromeda. The spectra were 
searched against the UniProt Human 
Reference Proteome, accessed on August 
2012. The table includes all instances of 
peptide identifications and quantitations, 
and their database search scores and 
posterior error probabilities.
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Ly T, Ahmad Y,  
Shlien A, Soroka D, 
Mills A, Emanuele MJ, 
Stratton MR,  
Lamond AI
2014 Raw Mass 
Spectra
PX000678; http://www. 
ebi.ac.uk/pride/archive/
projects/PXD000678
Publicly available at the EBI PRIDE 
database (http://www.ebi.ac.uk/pride/
archive/).
Ly T, Ahmad Y,  
Shlien A, Soroka D, 
Mills A, Emanuele MJ, 
Stratton MR,  
Lamond AI
2014 RNA- 
Sequencing 
Reads
EGAD00001000736; 
https://www.ebi.ac.uk/
ega/datasets/
EGAD00001000736
Publicly available at the EBI European 
Genome-phenome Archive (https://www.
ebi.ac.uk/ega/home).
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